The Saccharomyces cerevisiae CDC7 protein kinase, a potential link between START and the initiation of DNA replication by Yoon, Hye-Joo
The Saccharomyces cerevisiae CDC7 Protein Kinase, 
a Potential Link between START and 
the Initiation of DNA Replication 
Thesis by 
Rye-Joo Yoon 
In Partial Fulfillment of the Requirements 
for the Degree of 
Doctor of Philosophy 
California Institute of Technology 
Pasadena, California 
1992 
(Submitted December 17, 1991) 
11 
To My Parents 
Soo Nam and Y 00 Deug Yoon 
and 
Soon Ah and Chul Mo Shin 
ill 
ACKNOWLEDGEMENTS 
I would like to thank my research advisor, Judy Campbell, for her advise and en-
couragement during my graduate career. I would also like to thank the rest of my commit-
tee, John Abelson, Bill Dunphy, Carl Parker, and Jack Richards, for their time and inter-
est. 
All the members of the Campbell lab, past and present, deserve special thanks for 
sharing their scientific experience as well as good friendship . I thank Colin Gordon and 
Karen Sitney for their countless suggestions and pep talks. I am grateful to Seng Loo, 
who was a collaborator on the work presented in Chapter IV. Thanks to Rati Verma for 
helpful discussions. I would like to acknowledge the support and encouragement of my 
parents and my parents-in-law. Finally, I would like to thank my husband, Seung Koo 
Shin, for his endless love and support. In addition, he deserves special mention for help-
ing me make the best CDC7 antibodies. 
iv 
ABSTRACT 
Two major controls of the eukaryotic cell cycle exist in the G l/S and G2/M transi-
tions. In an attempt to understand the molecular basis of the G 1/S regulatory pathway, bio-
chemical characterization of the Saccharomyces cerevisiae CDC7 protein has been carried 
out. The temperature sensitive cdc7 mutation arrests yeast cells at the G 1/S phase bound-
ary. after the completion of START and prior to the initiation of DNA synthesis. START 
is defmed as the point of commitment to DNA replication in yeast. The open reading frame 
encoding CDC7 protein contains the 11 catalytic domains characteristic of protein kinases. 
That CDC7 protein indeed has protein kinase activity was demonstrated by incubating 
CDC7 immune complexes with histone HI. Kinase activity was elevated more than 
10-fold in strains carrying the wild-type CDC7-overproducing plasmid. Overproduction of 
thermolabile cdc7 protein gave rise to overproduction of thermolabile kinase. In vivo 
32P-Iabeling of yeast cells revealed that CDC7 protein itself was a phosphoprotein. In 
addition, indirect immunofluorescence and biochemical fractionation studies showed CDC7 
was located mainly in yeast nuclei. 
The cell cycle-specific roles of CDC7 at the G 1/S border were explored by follow-
ing the phosphorylation state and kinase activity of CDC7 protein throughout the cell cycle. 
CDC7 was not active as a histone HI kinase, nor was it phosphorylated in cells arrested by 
a cdc28 mutation. Furthermore, phosphorylation of CDC7 protein was required for its ac-
tivity. CDC28 encodes the budding yeast homolog of the highly conserved p34Cdc2/MPF 
kinase subunit and its function is crucial to passage through START. The possibility that 
CDC7 is a substrate of the CDC28 kinase was tested using CDC28 immune complexes and 
bacterially produced, inactive CDC7 kinase. The CDC28 kinase specifically phospho-
rylated the CDC7 protein. which in tum led to activation of the CDC7 kinase. CDC28 and 
CDC7 could interact in vivo as well since CDC7 hyperexpression suppressed the inviability 
of a cdc28 mutation at 33°C but not at 36°C. Finally, possible mechanisms of action of 
CDC7 protein kinase in the initiation of DNA synthesis were examined by searching for , 
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endogenous substrates among yeast replication proteins. The 34 kDa subunit of yeast 
replication protein-A (RP-A) is a substrate of both CDC7 and CDC28 kinases. 
In conclusion, the biochemical evidence indicates that there is a phosphorylation 
cascade operating between START and the initiation of DNA replication involving yeast 
CDC28, CDC7, and RP-A. 
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The eukaryotic cell cycle involves an ordered sequence of events that results in cell 
reproduction. Two major controls regulating the molecular events of a cell cycle exist in 
the G 1 to S phase and G2 to M phase transitions. In the past decade, the study of cell cycle 
control has been focused on the ubiquitous p34cdc2 protein and its associated regulatory 
components. p34cdc2 was first identified in yeast as a product of the cell division cycle 
(CDC) gene CDC28 (Saccharomyces cerevisiae)/cdc2+ (Schizosaccharomyces pombe). 
CDC28/cdc2+ encodes a pivotal protein-serine/threonine kinase that is conserved through-
out phylogeny. In yeast, both genes are required alleast twice in the cell cycle, once in G I 
for commitment to DNA synthesis and in G2 for entry into M phase (Nurse and Bissett, 
1981; Piggott et al., 1982). Thus, it appears that the same protein kinase is involved in 
regulating the two principal cell cycle transitions, G l/S and G2/M (Ghiara et aI., 1991; 
Surana et aI., 1991). 
For the control of mitosis, a universal mechanism common to all eukaryotes has 
now emerged: entry into M phase is determined by activation of the M phase-promoting 
factor (MPF) (Dunphy and Newport, 1988; Nurse, 1990). MPF is a protein complex, 
minimally consisting of the p34Cdc2 protein kinase and one of the regulatory subunits 
known as mitotic cyclins. Cyclins are a family of proteins whose abundance oscillate dur-
ing the cell cycle. Assembly of the p34Cdc2-cyclin complex as well as dephosphorylation of 
the p34Cdc2 protein leads to activation of the M phase-specific kinase, which in turn pro-
motes the G2/M transition by phosphorylating key proteins involved in the major M phase 
events (Lewin, 1990; Nurse, 1990). As compared to the G2/M control, much less is 
known about the molecular events leading to the initiation of nuclear DNA replication at the 
G l/S border. The budding yeast Saccharomyces cerevisiae provides an ideal system to 
study the G l/S control, since it is an organism whose cell cycle is regulated mainly in G 1. 
In fact, in S. cerevisiae, most mutant alleles of CDC28 cause arrest at a point in GI termed 
"START." START defmes an important decision point at which yeast cells can undertake 




They may initiate DNA synthesis and begin the mitotic cell cycle. They may fuse with cells 
of opposite mating type to form zygotes, or they may enter stationary phase in the absence 
of nutrients. Diploid cells can undergo the meiotic cycle after N-starvation and completion 




occur for diploids 
after N-starvation 
and completion of 
CDC4step 
"GO" ... E--T_A_R_VA_T_I_O_N;-----'---'NUTRIENT 
t----~ MITOSIS 
Presence of mating 
pheromone and 
haploid cells of 
opposite mating type 
~ 
CONJUGATION 
Figure 1. "START" as a decision point. Cells arrested in the Gl phase at 
START can, on release, develop in one offour different ways depending on the 
nature of the cell and its environment, as summarized in the diagram. "GO", 
non-proliferation. Reproduced from Wheals (1987). 
Once past START, cells are committed to complete the ongoing round of DNA 
replication even in the absence of nutrients or in the presence of mating pheromones. 
Passage through START requires the activity of CDC28 protein, a budding yeast analog of 
the highly conserved p34cdc2 protein kinase. START also requires three cyclin-like pro-
teins encoded by CLN}, CLN2, and CLN3. The CLN genes were originally isolated as 
suppressors of cdc28 mutations (CLN) and CLN2) or as dominant mutant alleles that ad-
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vanced cells into START at a reduced size (CLN3) (Cross, 1988; Hadwiger et ai., 1989; 
Sudbery et ai., 1980). It has been proposed that the CLN genes encode components of a 
G I-specific form of the CDC28 kinase, whose activation is the signal for cells to pass 
START (Nash et aI., 1988; Richardson et aI., 1989; Wittenberg et al., 1990). A current 
model for cell cyele control in S. cerevisiae is shown in Figure 2. The CLB genes encode 
the G2 cyclins, i.e., mitotic cyclins, of the budding yeast. So far, the G 1 cyelins have 
been fully characterized only in S. cerevisiae. 
START 
V 
S G2 M 
r 
Figure 2. A model for cell cyele regulation in S. cerevisiae. It is proposed that the cell 
cycle in S. cerevisiae is controlled at two major transitions, namely, Gl/S and G2/M. A 
successful execution of both transitions requires two distinct forms of a protein kinase. 
Although both forms contain a common catalytic subunit encoded by the CDC28 gene, the 
proteins associated with it differ. While the fully active G 1 kinase requires the interaction 
of CDC28 with Gl cyelins, the formation of G2 kinase involves association with G2 
cyelins. The interaction with distinct cyelins may provide a way to modulate the substrate 
specificity or timing of action of the catalytic subunit CDC28. Adapted from Surana et al. 
(1991). 
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The discoveries of G 1 cyclins have been a major breakthrough in elucidating the 
mechanism of START. What is lacking is any information on the molecular nature of the 
events set in motion by CDC28 and the other START genes. While the commitment to 
DNA synthesis is made by passage through START, DNA synthesis does not begin im-
mediately. A number of additional genetically defined steps must occur before the onset of 
DNA replication. It is likely that both induction of the genes encoding replication proteins 
and post-translational activation of replication proteins are preconditions for the initiation of 
DNA synthesis. The CDC28, CDC4 and CDC7 genes are thought to define one series of 
steps that must be completed before the initiation of DNA synthesis (Hartwell, 1976; 
Pringle and Hartwell, 1981). Morphological analysis of single and double mutants and re-
ciprocal shift studies suggest that CDC4 and CDC7 act subsequent to CDC28/START 
(Hereford and Hartwell, 1974). 
In addition to CDC4 and CDC7, three other genes, CDC34, DBF4, and possibly 
DBF2 also function in the post-START/pre-DNA synthesis period (Goebl et aI., 1988; 
Johnston and Thomas, 1982; Chapman and Johnston, 1989; Johnston et al., 1990). 
CDC34 and CDC4 share the same terminal phenotype, a multi budded, uninucleate struc-
ture, in which the spindle pole body has duplicated but not separated. CDC34 encodes a 
ubiquitin conjugating enzyme. One domain of CDC4 is homologous to the lJ-subunit of 
transducin while another is similar to the ets oncogene (pong et al., 1986; Peterson et al., 
1984). dbf4 mutants show a dumbbell shaped terminal phenotype typically associated with 
a -DNA synthesis or nuclear division defect (Johnston and Thomas, 1982). Furthermore, 
the terminal phenotype of dbf4cdc4 and cdc7cdc4 double mutants is that of cdc4, implying, 
if they are on the same pathway, that cdc4 precedes cdc7 and dbf4 (Hereford and Hartwell, 
1974; Johnston and Thomas, 1982). DBF4 encodes a 2.4 kb mRNA, but its function 
could not be deduced from its sequence (Chapman and Johnston, 1989). DBF2 encodes a 
protein kinase with an execution point in G2/M (Johnston et aI., 1990). There may also be 
an effect on Gl, though the only evidence for this thus far is that recovery from a-factor is 
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retarded, as measured by a delay in the initiation of DNA synthesis after a-factor removal. 
The timing of DBF2 function is obscured by the apparent redundancy of this protein 
kinase, since a gene encoding a second kinase with significant homology to DBF2 and the 
ability to complement dbj2 has been identified (Johnston et al., 1990). 
CDC7 is believed to execute its function late in Gl, since cells carrying a thermo-
sensitive (ts) cdc7 mutation block mitotic growth at the G liS phase boundary at the restric-
tive temperature, just before the initiation of DNA synthesis (Hartwell, 1973; 1976). These 
cells resemble dbf4 mutants, in that they arrest with large budded cells, Le., dumbbells, 
with spindle pole body duplicated, and separated, but not completely elongated (Figure 3). 
Figure 3. Terminal phenotype and nuclear-related behavior of cells carrying a 
cdc7 mutation. Adapted from Wheals (1987). 
Another reason for placing CDC7 function very late in G 1 is the fact that cdc28 and 
cdc4 mutants blocked at the nonpermissive temperature and then returned to the permissive 
temperature in the presence of the protein synthesis inhibitor cycloheximide do not progress 
further through the cycle and do not enter S phase, while cdc7 mutants treated in the same 
way enter S phase and complete DNA synthesis in the presence of protein synthesis inhibi-
tors (Hereford and Hartwell, 1974). Further protein synthesis is thus necessary for the in-
itiation of DNA synthesis after CDC28 and CDC4, whereas all of the proteins essential for 
DNA replication appear to be present at the CDC7 stage. Further protein synthesis is also 
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required after return of dbf4 mutants from the nonpermissive temperature for entry into 
S phase (Johnston and Thomas, 1982). CDC7 thus mimics the final stage of the 
restriction point in mammalian cells, insofar as it was defined as the point in the cell cycle 
after which no further protein synthesis is necessary for initiation of DNA synthesis. 
Evidence suggesting the presence of CDC7 protein in a putative DNA replication complex 
also exists (Jazwinski, 1988). Since CDC7 appears to be required only for the final stage 
of the G liS transition, we speculated that CDC7 might serve as a molecular link between 
START and the onset of DNA synthesis. In an effort to understand the regulatory 
apparatus operating at the G liS border, we set out to determine the biochemical basis for 
the role of CDC7 protein in the G liS transition. 
The phenotype of cdc7 mutants suggests that the CDC7 protein performs multiple 
functions in the life cycle of S. cerevisiae. As mentioned above, cdc7 mutant cells show 
defects in the initiation of mitotic DNA synthesis. Though basal level expression requires 
an element in the promoter that is homologous to a c-fos activating sequence, CDC7 
mRNA remains at a constant level throughout the ceU cycle when measured in cells released 
from <x-factor arrest (Ham et al., 1989; Sclafani et al., 1988). In addition, a cell carrying a 
deletion of CDC7 on the chromosome can divide up to eight times after loss of a plasmid 
harboring the CDC7 gene, suggesting that the CDC7 protein exists in excess of the amount 
required for a single mitotic cell division (Sclafani et al., 1988). 
In contrast to the behavior during mitosis, diploid homozygous cdc7-ts cells initiate 
premeiotic DNA synthesis normally at the restrictive temperature. However, these diploids 
do not form a synaptonemal complex, nor do they commit to recombination or form ascos-
pores (Schild and Byers, 1978). Furthermore, the abundance of CDC7 mRNA varies dur-
ing the meiosis, with its peak occurring at recombination (Sclafani et aI., 1988). The cdc7 
lesion seems to affect the mitotic and meiotic pathways in a different, distinct manner. The 
execution points of CDC7 are illustrated in Figure 4. The CDC7 gene has also been impli-
cated in an error-prone DNA repair pathway as a member of the RAD6 epistasis group 
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(Njagi and Kilbey, 1982). Finally, CDC7 may also be involved in transcriptional silencing 
of the HMR mating type cassette (Axelrod and Rine, 1991). 
Vegetative Phase Meiotic Phase 
G1 Phase 
Figure 4. Execution points of CDC? in the mitotic and meiotic cell cycles. 
Modified from Hoekstra et al. (1991). 
How does CDC7 affect these different DNA processes and what controls the timing 
of CDC7 function in the cell cycle? A clue to investigate the molecular function of CDC7 
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was afforded by the demonstration that the open reading frame encoding CDC7 contains 
the 11 catalytic domains characteristic of protein kinases (Patterson et aI., 1986). These 
catalytic domains range from 250 to 300 amino acid residues, corresponding to about 
30 kDa. Subdomains VI and VIII are of particular interest in that they contain residues that 
are specifically conserved in either the protein-serine/threonine or the protein tyrosine 
kinases (Hanks et aI., 1988). According to this indicator, CDC7 encodes a protein-
serine/threonine kinase. The CDC7 sequence, however, differs from that of other protein 
kinases in spacing between conserved subdomains. Very large inserts (in excess of 60 
residues) occur in CDC7 between subdomains VII and VIII and between subdomains X 
and XI (Hanks et al., 1988). Thus, it was a matter of interest whether or not CDC7 carries 
a protein kinase activity. Since protein phosphorylation is an important regulatory 
mechanism of cell cycle progression, biochemical characterization of the putative kinase 
activity of CDC7 will further our knowledge of cell cycle control. 
In order to demonstrate the kinase activity of CDC7, we isolated the CDC7 gene by 
complementation of a cdc7 mutation and subcloned it into Escherichia coli. Because of the 
reportedly low background of protein phosphorylation in E. coli, we thought that the 
putative kinase activity of CDC7 could be tested easily after overproducing the protein. 
The results of this work are described in Chapter ll. 
The initial strategy of characterizing CDC7 in E. coli turned out to be unfruitful. 
We could not detect CDC7-dependent kinase activity even after partially purifying the 
protein. Two plausible reasons for failure to detect active CDC7 in E.coli led us to refocus 
our studies on yeast. First, despite the fact that the amino acid sequence of CDC7 has 
homology to protein kinases, CDC7 may not function as a protein kinase. Second, CDC7 
may not be active in E. coli because, like CDC28, activation of CDC7 kinase requires other 
proteins of yeast. We preferred the latter interpretation, and decided to carry out further 
analyses of CDC7 made in yeast. In Chapter III, I describe the generation of polycIonal 
antibodies against CDC7 . and the subsequent use of these antibodi~s to characterize the 
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protein kinase activity, post-translational modifications, and subcellular locations of CDC7 
in yeast. Demonstration that CDC7 encodes a protein kinase led us to test the hypothesis 
that CDC7 phosphorylates a protein(s) in the replication apparatus. Furthermore, since 
CDC7 is a phosphoprotein with a protein kinase activity and functions only after 
completion of START, we tested the idea that CDC28 kinase activates CDC7 kinase via 
phosphorylation. These studies are described in Chapter IV. 
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CHAPTER II 
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the Yeast CDC7 Protein in Escherichia coli 
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Abstract 
The cdc7 mutation of Saccharomyces cerevisiae arrests cells late in the G 1 phase of 
the cell cycle, just prior to the initiation of mitotic DNA synthesis. The nucleotide sequence 
of the CDC7 gene encodes a protein which has strong homology to protein kinases. To 
characterize the CDC7 protein, we introduced the gene into Escherichia coli by using a 
bacteriophage 17 expression system, and carried out enzymatic phosphorylation assays. 
An in vitro autophosphorylation assay and other protein kinase assays indicate that E. coli 
contains an endogenous autophosphorylatable protein of the same molecular weight as the 
CDC7 protein. In order to separate the E. coli kinase from the CDC7 protein, we partially 
purified the CDC7 protein using 35S-labeled CDC7 protein as a probe. Unfortunately, we 
were not able to separate the E. coli kinase from the CDC7 protein. Since the CDC7 
protein was not expressed at high levels in the 17 system, the gene was recloned into the 
tac expression system and was overproduced in E. coli after IPTG induction. Antibodies 
were raised against the overproduced protein, and antipeptide antibodies were made against 
the last 8 amino acids of CDC7. 
18 
Introduction 
The mitotic cell cycle is made up of the events and processes that take place between 
the birth of the cell and its subsequent division into two daughters (vegetative cellular 
reproduction). Like the cell cycles of other eukaryotes, the yeast cell cycle is divided into a 
G 1 phase (pre-DNA synthesis), an S phase (chromosomal DNA replication), a G2 phase 
(post-DNA synthesis), and an M phase (mitosis) (Pringle and Hartwell, 1981). 
Approximately 70 genes with a CDC (cell division cycle)-related phenotype have been de-
tected in Saccharomyces cerevisiae and over 30 gene products that are required for a spe-
cific step in the cell division cycle have been identified by temperature sensitive (ts) muta-
tions (reviewed in Wheals, 1987). Since a cdc mutation leads to a defect in a particular 
stage-specific function of the cell cycle, the cdc mutant cells are unable to complete the cell 
cycle, and should accumulate at the same stage (the terminal phenotype). Thus, an initially 
heterogeneous asynchronous culture should become synchronous and homogeneous 
(Pringle and Hartwell, 1981). A number of cdc mutants defective in some aspects of DNA 
synthesis have been detected, and some of them have been characterized. CDC9, for in-
stance, is the structural gene for DNA ligase (Barker and Johnston, 1983). Mutations in 
two genes (CDC4 and CDC7) appear to block a precondition for DNA synthesis because 
cells carrying these lesions can not start new rounds of DNA replication after a shift from 
permissive to nonpermissive temperature (Hartwell, 1973). 
Since we have been interested in the regulation of yeast DNA replication and the 
cdc7 mutation arrests cells late in G 1, just prior to the initiation of mitotic DNA synthesis, 
we decided to identify the CDC? protein and characterize its precise function. The terminal 
phenotype of the cdc7 mutant appears as budded cells with a single nucleus but without an 
elongated spindle apparatus (Byers and Goetsch, 1974). It is not clear at this moment 
whether the CDC7 protein just promotes entry into S phase or if it is directly involved in 
the initiation of DNA synthesis. Furthermore, the initiation of meiotic replication is not 
affected in cdc7 mutants, in contrast to the requirement for the CDC7 gene product to 
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initiate mitotic DNA synthesis (Schild and Byers, 1978). The protein synthesis re-
quirement for mitotic DNA replication may be completed before the CDC7-mediated step 
because protein synthesis is not needed for DNA synthesis after arrest at the cdc7 block 
(Hereford and Hartwell, 1974). Although it is not required for the initiation of meiotic 
replication, it is necessary for genetic recombination during meiosis and for the formation 
of ascospores (Schild and Byers, 1978). Thus, the cdc7 mutants are defective in mitotic 
and meiotic cell cycles like nearly all of the cdc mutants that are defective in spindle pole 
body duplication or segregation, DNA replication, and chromosome segregation (Simchen, 
1974). But the CDC7 protein may function in each pathway quite differently. CDC7 is 
also implicated in error-prone DNA repair since the mutant cdc7-1 shows a reduction in in-
duced mutagenesis with DNA damaging agents (Njagi and Kilbey, 1982). 
The CDC7 gene has been cloned and its entire coding region has been sequenced 
(Patterson et a!., 1986). The RNA transcript of CDC7 is about 1,700 nucleotides 
(Patterson et al., 1986). Transcript levels do not vary during the mitotic cell cycle but they 
do during meiosis (Sclafani et al., 1988). The coding region has an open reading frame of 
1,521 nucleotides, which encodes a Mr 56,000-58,200 protein with homology to protein 
kinases (Patterson et al., 1986). The CDC7 protein has significant homology with the 
CDC28 gene product and other protein kinases (Patterson et al., 1986). The CDC28 pro-
tein kinase is presumably a component of a signal transduction pathway that conveys in-
formation from the exterior of the cell to the machinery that controls exit from Gl 
(Mendenhall et al., 1987). CDC28 is required for movement past a point in Gl called 
"START" (Reed, 1980). The function of the CDC7 protein in the G1 phase to S phase 
transition and/or in the initiation of mitotic DNA replication may be accomplished by its 
protein kinase activity, as the CDC28 protein kinase may allow actively dividing cells to 
pass START by phosphorylating a Mr 40,000 protein during the G 1 phase (Mendenhall et 
al., 1987; Reed et al., 1985). 
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Whatever the function of CDC7 is, it must be very important in the control of the 
cell division cycle and/or in the mechanism of yeast DNA replication. In this chapter, we 
describe the cloning and overexpression of the CDC7 gene, the characterization of its enzy-
matic activity, and the partial purification of the gene product in Escherichia coli. 
Materials and Methods 
Strains and Media 
E. coli K38 (HfrC) and JMlOl (supE, thi, ~(lac-proAB), [F', traD36, proAB, 
lacIQUMlS]) were used for cloning and expression of the CDC7 gene. E. coli cells were 
grown in LB, supplemented M9, or M9CA medium (Maniatis et aI., 1982); ampicillin 
and/or kanamycin were added to media in a final concentration of 50 Ilg!rnl or 40 llg!mI. 
S. cerevisiae strain used in this work was cdc7 (a adel ura3-52 tyrl his7 lys2 gall 
cdc7-l). Yeast extract-peptone-dextrose (YPD) or supplemented synthetic minimal 
medium was used for the culture of yeast cells (Sherman et al., 1986). 
Chemicals 
[35S] methionine and [y32p] ATP were obtained from ICN. Carrier-free [32p] 
orthophosphate and [3H] amino acid mixture were purchased from Amersham. Histones, 
casein, phosvitin, protamine, and Kemptide were products of Sigma. 
Yeast Genomic Library 
The recombinant plasmid pool containing yeast DNA sequences in a centromere-
containing vector YCpSO (Kuo and Campbell, 1983) was used to complement the cdc7-1 
mutation. 
Cloning 
Restriction enzymes, calf intestinal alkaline phosphatase, E. coli Klenow fragment, 
T4 DNA ligase, and T4 DNA polymerase were purchased from New England Biolabs or 
Bethesda Research Laboratories and were used according to the supplier's instructions. 
T7 RNA polymerase/promoter expression system, Sphl linker, and pKK223-3 were 
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generously provided by S. Tabor, M. Budd, and N. Gautum, respectively. 
Oligonucleotides were synthesized by Microchemical Facilities at Caltech and were purified 
by FPLC. Isolation of plasmid DNA, preparation of DNA fragments, and transformation 
of E. coli were carried out as described elsewhere (Maniatis et al., 1982). 
Purification 
One ml of cells (E. coli K38/pGPI-2/pTI-CDC7) was labeled with 1 mCi of [35S] 
methionine in the presence of rifampicin (400 ~g/ml) after heat induction and used as a 
radioactive probe to purify the CDC7 protein from a large culture as described below. Ten 
liters of cells (E. coli K38/pGPI-2/pT7-CDC7) were grown with aeration in a New 
Brunswick fermentor at 30°C in M9CA medium, pH 7.4. At OD600 = 0.5, the temperature 
was raised to 42°C. After 30 min, the temperature was lowered to 37°C for 120 min. Cells 
(35 g) were harvested, washed with 2 liters of 20% (w/v) sucrose, 50 mM Tris-HCI at pH 
7.5, 10 mM EDTA at pH 8.0, and 150 mM NaCI (lysis buffer), at O°C, resuspended in 
150 ml of lysis buffer, dispensed into 30 ml-aliquots, and frozen in liquid N2 until needed. 
Cells (30 ml) were thawed at O°C and mixed with 1 ml of radioactive cells. Lysozyme was 
added to 0.2 mg/ml. After 45 min at O°C, the cells were twice frozen in liquid N2 and 
thawed at O°C. The lysate was centrifuged and the supernatant was collected (fraction I, 
25 ml). Ammonium sulfate (9.75 g) was added to fraction I at O°C over 45 min. The 
precipitate was centrifuged and resuspended in 10% (v/v) glycerol, 50 mM Tris-HCl at pH 
8.0, 1 mM EDTA, 0.5 mM dithiothreitol (OT!), 1 mM PMSF, and 1 mM benzamidine 
(buffer A) to a conductivity equal to that of buffer A containing 50 mM NaCI (fraction II, 
40 ml). Fraction II was applied to a c~lumn of Whatman DE52 DEAE-cellulose (7 cm2 x 
9 cm) and the column was washed with 300 ml of buffer A containing 50 mM NaCl. 
Protein was eluted with a 600 ml-linear gradient from 50 to 400 mM NaCI in buffer A. 
The CDC7 protein was eluted from 90 to 230 mM NaCI (fraction III, 240 ml). Fraction m 
was concentrated by ammonium sulfate precipitation and loaded on a column of Whatman 
Pll phosphocellulose (3.14 cm2 x 1.9 cm) equilibrated with 10% (v/v) glycerol, 50 mM 
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Tris-HCI at pH 7.2,0.1 mM EDTA, 0.5 mM DTT, 1 mM PMSF, and 1 mM benzamidine 
(buffer B) containing 50 mM NaCI. The column was eluted with buffer B in a series 
containing NaCI at concentrations, 0.05, 0.1, 0.2, 0.4, 0.6, and 1.0 M. The CDC7 
protein was eluted at 1.0 M NaCI. 
Preparation of Antipeptide Antibodies 
Peptide was synthesized by Microchemical Facilities at Caltech. Two New Zealand 
white rabbits (one for the free peptide, the other for the conjugated peptide) were immu-
nized according to the following schedule: fIrst, 250 Jlg peptide-coupled KLH (keyhole 
limpet hemocyanin) in complete Freund's adjuvant (1:1) at multiple subcutaneous sites on 
day 0; second, 250 Jlg in incomplete Freund's adjuvant (1:1) subcutaneously on day 21. 
The rabbit was bled 5 weeks after the fIrst injection. After these initial injections, the rabbit 
was boosted with 250 Jlg peptide-coupled KLH emulsilled with incomplete Freund's adju-
vant (1:1) at 5 week intervals, and bled 10 days after the injection. The nonconjugated 
peptide was injected according to the same schedule except that 500 Jlg peptide was used 
per injection. 
Other Methods 
Protein concentrations were determined with the Bio-Rad protein assay kit. For 
Western blots, proteins were transferred from SDS-polyacrylamide gels to nitrocellulose as 
described in detail elsewhere (Towbin et al., 1979). The CDC7 protein was detected by the 
procedure explained in the Bio-Rad ImmunBlot assay kit 
Results 
Isolation of a DNA Fragthent Able to Complement the cdc7 Mutation 
The CDC7 gene was isolated by transformation of a uraJ-52 derivative of strain 
cdc7 with a YCp50 yeast genomic library constructed in this laboratory (Kuo and 
Campbell, 1983). URA+ transformants were selected at 23°C and a transformant carrying 
the CDC7 gene was identifIed by replica plating and testing for complementation of the , 
23 
temperature sensitive phenotype (A. long). The gene was verified by standard procedures 
and the restriction map coincided with the published one (Patterson et at, 1986). 
Expression of the CDC7 Gene in the T7 RNA Polymerase/Promoter System 
The bacteriophage 17 expression system was used to express the CDC7 gene in 
E. coli as described previously (Tabor and Richardson, 1985). This system consists of 
two plasmids, pGPl-2 and p17-7. pGP1-2 contains the 17 RNA polymerase gene under 
the control of the inducible A PL promoter and the gene for the heat-labile A repressor, 
cI857. p17-7 has a 17 RNA polymerase promoter, q,1O, and a 16S ribosome binding site, 
followed by a polylinker containing ten different restriction enzyme sites. The CDC7 gene 
was inserted into the polylinker region of the plasmid p17-7 and expressed in E. coli after 
heat induction of 17 RNA polymerase and the addition of rifampicin to tum off E. coli 
RNA polymerase transcription. The plasmid which had the insert of the CDC7 coding 
region was named p17-CDC7. The addition of [3H] amino acid mixture or [35S] methio-
nine resulted in specific labeling of the CDC7 protein. Figure 1 shows the profile of [35S] 
methionine-labeled proteins in E. coli. 
Protein Phosphorylation in E. coli 
Protein phosphorylation has been recognized as a major regulatory process in a 
number of eukaryotic systems (Krebs and Beavo, 1979), and has recently been shown to 
occur in bacteria as well (Manai and Cozzone, 1979; Wang and Koshland, 1981). Despite 
the presence of some phosphoproteins in E. coli, Wang et al. have expressed the oncogene 
v-abl of Abelson murine leukemia virus in E. coli and demonstrated that this coding 
sequence gives rise to a Mr 62,000 protein which is phosphorylated on a tyrosine residue 
in bacterial cells carrying the v-abl gene (1982). The same approach was taken here to 
investigate whether the CDC7 protein was phosphorylated in E. coli. Cells containing 
p17-7 orp17-CDC7 were labeled with [32p] orthophosphate and celllysates were analyzed 
by SDS-polyacrylamide gel electrophoresis and autoradiography (Figure 2A). The 
calculated size of the CDC7 protein is 58,200 or 56,000 daltons, depending on which of 
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two possible ATG codons initiates translation. As shown in Figure 2A, a Mr 58,000 
protein was strongly phosphorylated in vivo. This protein may be, however, a bacterial 
gene product because it was present in the absence of heat induction and even in cells 
harboring the control plasmid only. Basically, the same result was obtained with cell 
lysates labeled in vitro with [y_32p] A TP (Figure 2B). It is not clear from these 
experiments whether the CDC? protein was phosphorylated in E. coli. 
In Vitro Assay for Autophosphorylating Activity 
Homology between the CDC7 gene product and other protein kinases is not dis-
tributed randomly throughout the coding sequences, but it is confined largely to two func-
tional regions, the A TP-binding region and the phosphorylation site receptor region 
(Patterson et aI., 1986). Consensus sequences are known to be present in both regions. 
The phosphorylation receptor residue in tyrosine kinases is either a tyrosine 7 residue after 
the arginine/lysine position in the consensus or an adjacent threonine (Hunter and Cooper, 
1985). In cAMP-dependent protein kinases, a threonine 8 residue after the arginine/lysine 
position is autophosphorylated (Shoji et aI., 1979). The CDC7 protein has a tyrosine 5 
(Tyr 192) and a serine 7 (Ser 194) in this region. Autophosphorylation has been taken as 
good evidence that a protein can function as a protein kinase (e.g., Celenza and Carlson, 
1986). To test whether CDC7 carried an autophosphorylating activity, an in situ 
autophosphorylation assay described by Celenza and Carlson (1986) was used. Mn2+, 
Zn2+, and Ca2+ as well as Mg2+ were used as cofactors. The results are shown in Figure 
3. Again, in both the control and the CDC7-containing extracts, there was a labeled Mr 
58,000 band regardless of the type of cations used. Thus, E. coli has an endogenous 
autophosphorylatable species with the same migration in SDS gels as the CDC7 protein. 
To see if the CDC7 protein comigrated with the endogenous activity, extracts were 
analyzed by two-dimensional gel electrophoresis according to O'Farrell (1975) and assayed 
for autophosphorylating activities. However, we could not detect any 
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autophosphorylatable proteins in this experiment due to the low sensitivity of this technique 
(data not shown). 
Exogenous Protein Phosphorylation in E. coli 
We also used exogenous proteins as substrates to detect CDC7-dependent kinase 
activity. E. coli extracts were prepared as usual, incubated in a buffer containing [y_32p] 
ATP, Mg2+, and either different subgroups of histones, protamine, casein, or phosvitin. 
The reaction products were subjected to SDS-polyacrylamide gel eletrophoresis and visual-
ized by autoradiography. To make sure that the phosphorylation of foreign substrates was 
achieved by proteins in extracts and not by proteins contaminating the substrates, the sub-
strate proteins were incubated with [y_32p] A TP in the absence of extracts and used as con-
trol. The results are shown in Figure 4. Neither casein nor protamine were phosphory-
lated. But histones and phosvitin were phosphorylated even in extracts lacking the CDC7 
protein. Since phosvitin was labeled in a control as well, its phosphorylation does not ap-
pear to be carried out by E. coli proteins. The reason that histones were phosphorylated by 
E. coli proteins remains to be clarified. Based on the requirement of cofactors, protein 
kinases may be classified into different types, for instance, cAMP-dependent protein 
kinase, etc. Since the protein phosphorylation in E. coli has been known to be cyclic 
nucleotide independent (Dadssi and Cozzone, 1985), we carried out another protein kinase 
assay, this time using a synthetic peptide Kemptide as substrate. To determine the effect of 
cyclic nucleotides on kinase activity, the extracts were fractionated on a DE52 column, and 
fractions were assayed in the presence of either cAMP or cGMP by using phosphate 
acceptor peptide Kemptide as substrate. No difference was seen whether cyclic nucleotides 
were added or not (data not shown). 
Partial Purification of the CDC7 Protein 
To determine the precise function of the CDC7 protein, we decided to purify the 
protein before assessing its activity. Since the CDC7 protein represented the major band on 
SDS-polyacryla.onde gels when E. coli cells were labeled with [35SJ methionine in the 
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presence of rifampicin, we used this radioactive protein as a probe to purify the CDC7 
protein from extracts of a large culture of unlabeled cells. The extracts were fractionated by 
ammonium sulfate, followed by chromatography on DEAE and phosphocellulose. After 
each chromatography, samples were taken from each fraction and counted to detect the 
fractions containing the CDC7 protein. The results were confIrmed by SDS-polyacry-
lamide gel electrophoresis. On a DE52 DEAE-cellulose column, the CDC7 protein was 
eluted from 90 to 230 mM NaCI with a linear gradient from 50 to 400 mM NaC!, reaching 
a peak approximately 150 mM NaCI (Figure 5). The fractions containing the CDC7 protein 
were further fractionated on a column of Pll phosphocellulose with a N aCI step gradient. 
The CDC7 protein eluted at 1.0 M NaCI (Figure 6). Since CDC7 protein was not 
expressed at high levels in the T7 system, we decided to clone the gene in a different 
expression system and further overproduce the protein (see below). 
Autophosphorylating Activities after DEAE-Cellulose Chromatography 
We next assessed whether, after DEAE-cellulose chromatography, we had 
separated the CDC7 protein from the E. coli Mr 58,000 protein (p58). Cells containing 
pT7-CDC7 or pT7-7 were fractionated on DEAE-cellulose columns, and then each fraction 
was assayed for autophosphorylating activities as described before (Celenza and Carlson, 
1986). Extracts prepared from CDC7-containing cells showed an autophosphorylated 
protein of Mr 58,000 eluting from 100 to 170 mM NaCI (Figure 7A), and extracts made 
from the vector containing cells gave rise to an autophosphorylatable p58 from 130 to 190 
mM NaCI (Figure 7B). Since both extracts showed autophosphorylatable proteins of Mr 
58,000 within the region of 90 to 230 mM NaCI in which the CDC7 protein eluted on a 
DEAE-cellulose column, the results are still not conclusive to demonstrate that the CDC7 
protein is autophosphorylatable. 
Antisera to the CDC7 Gene Product 
The peptide homologous to the last 8 amino acids of the C-terminus of CDC7 (as 
predicted from the DNA sequence) was synthesized and coupled to KLH by succinimidyl 
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4-(N-MaIeimido methyl) cyclohexane I-carboxylate. Cysteine was added to the C-termi-
nus of the peptide to aIlow coupling to KLH (Liu et aI., 1979). This conjugated peptide as 
well as the nonconjugated one, were used to immunize two rabbits. Both the conjugated 
peptide and the nonconjugated peptide provided antibodies that recognized the CDC7 
protein expressed in E. coli on Western blots (data not shown). 
Overexpression of the CDC7 Gene in E. coli 
It was very difficult to purify the CDC7 protein, mainly because it was not 
overproduced in the 17 expression system. We, therefore, recloned the gene by using the 
strong trp-Iac (tac) promoter and succeeded in its overproduction. The expression vector 
pKK223-3 contains the tac promoter first described by DeBoer et aI. (1983), a multiple 
cloning site, and the strong rrnB ribosomal RNA transcription terminators (Brosius et aI., 
1981). The tac promoter bears the -35 region of the trp promoter and the -10 region, 
operator, and ribosome binding site of the lacUV-5 promoter (Amann et aI., 1983). In a 
lacIQ host, the tac promoter is repressed but may be induced by the addition of isopropyl 
j3-D-thiogalactoside (IPTG). The gene for CDC7 was subcloned into this expression 
vector, and the resulting plasmid was named pKK-CDC7. Briefly, CDC7 was brought 
under the control of the tac promoter by inserting the CIal/EcoRI fragment from CDC7 into 
the EcoRI site of the vector, and reconstituting the CDC7 coding sequence with the oligo-
nucleotide 5'-AA TIC ATG ACA AGC AAA ACG AAG AAT AT-3'. As shown in 
Figure 8, the CDC7 protein was overproduced in a lacIQ host, JM101, with its synthesis 
reaching a plateau 120 min after IPTG induction. The plasmid pKK223-3 was used as a 
control for this experiment. 
Discussion 
The 17 RNA polymerase/promoter expression system was originally chosen to 
produce the yeast CDC7 gene in E. coli because this expression system had advantages 
over other systems. In order to overproduce the products of a cloned gene, the T7 system 
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makes use of a very strong promoter, cj) 10, coupled to the ribosome binding site and the 
initiation codon, ATG (Tabor and Richardson, 1985). When the mRNA is efficiently 
translated after heat induction and in the presence of rifampicin, a target protein can 
accumulate to about 50% of the total cell protein (Studier and Moffat, 1986). Although the 
CDC7 protein was the most abundant protein in E. coli upon labeling with [35S] 
methionine (Figure I), we could not detect it on Coomassie blue-stained gels. This might 
be because T7 RNA polymerase was not as active as it was supposed to be and/or certain 
cis- and trans-acting elements of the yeast CDC7 gene were missing in E. coli. When we 
recloned the gene into the tac promoter/lPTG induction system, the protein was 
overproduced and represented a strong band on Coomassie blue-stained gels (Figure 8). 
The overexpression of the CDC7 gene, therefore, seems to be dependent upon which 
expression system is used to introduce the gene into E. coli. 
The nucleotide sequence of the CDC7 gene predicted a protein that had significant 
homology to the CDC28 protein kinase, cAMP-dependent protein kinases, and oncogene 
kinases (Patterson et aI., 1986). The phosphorylation site receptor domain of known 
protein kinases can be organized by itself into three regions including the middle spacer 
region in which tyrosine or threonine is phosphorylated or autophosphorylated (Hunter and 
Cooper, 1985). CDC7 contains 99 amino acid residues in this middle region, whereas 
other protein kinases have 16 to 21 amino acid residues. Since the organization of the 
phosphorylation site receptor domain in CDC7 is significantly different from all known 
protein kinases, this heterogeneity might modify the protein kinase activity of CDC7. To 
determine whether it is another CDC gene with protein kinase activity, we tlfSt looked for 
phosphoproteins and autophosphorylatable proteins in the E. coli cells containing the 
cloned CDC7 gene. As shown in Figures 2 and 3, E. coli had an unknown 
autophosphorylatable protein of the same molecular weight as the CDC7 protein (Mr 
58,000). Since bacterial protein kinases have been known to be cyclic nucleotide 
independent and to use mainly endogenous proteins as substrates, we carried out cAMP-
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and cGMP-dependent protein phosphorylations and exogenous protein phosphorylation in 
vitro in order to find any differences between cells containing the cloned CDC7 and cells 
carrying the vector alone. There was no cyclic nucleotide dependent phosphorylation in E. 
coli. Unexpectedly, however, histones were phosphorylated by E. coli extracts (Figure 4). 
Further experiments are needed to clarify this conflict. 
We have tried to characterize the yeast CDC7 protein in E. coli because of the low 
background of protein phosphorylation in E. coli and the unique properties of prokaryotic 
protein kinases. This suggested that the putative protein kinase activity of CDC7 should be 
easily demonstrated even without purifying the protein. However, E. coli has turned out to 
contain an endogenous autophosphorylatable protein of Mr 58,000, the same molecular 
weight as CDC7. This E. coli protein even copurified with the CDC7 protein in DEAE-
cellulose chromatography. In situ autophosphorylation assays after DEAE-cellulose 
fractionation showed that E. coli p58 eluted almost at the same salt concentrations as the 
CDC7 protein with a 50-400 mM NaCllinear gradient (Figure 7A and 7B). Furthermore, 
CDC7 may not be functional in E. coli because it requires other proteins or post-
translational modifications of yeast to be activated and/or substrate proteins of CDC7 are 
absent in E. coli. Therefore, as described in the next two chapters, we turned to methods 
for studying CDC7 in yeast. 
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Figure 1. Expression of the CDC7 Gene by T7 RNA Polymerase/Promoter 
System. 
E. coli K38/pGPI-2 containing pTI-7 (lane a) or pTI-CDC7 (lane b) were grown in M9 
medium supplemented with thiamine (20 ~g/ml) and 18 amino acids (0.01 %, minus 
cysteine and methionine). Cells (1.5 ml) were grown at 30°C until OD600 = 0.4. 
Temperature was shifted to 42°C for 20 min. Rifampicin (400 ~g/ml) was added, and after 
15 additional min at 42°C, cells were grown for 20 min at 30°C. After pulse labeling with 
10 ~Ci of [35S] methionine and chasing with cold methionine (4 ~g/ml), cells were har-
vested, resuspended in 60 mM Tris-HCI at pH 6.8, 1 % SDS, 1 % ~-mercaptoethanol, 10% 
glycerol, and 0.01 % bromophenol blue, boiled for 5 min and loaded onto a 12.5% SDS-
polyacrylamide gel. To reduce the X-ray film exposure time necessary for visualization, 
the gel was treated with an autoradiography enhancer. The numbers on the left give the 











Figure 2. In Vivo and In Vitro Protein Phosphorylation In E. coli. 
(A) E. coli cells were grown on minimal medium containing 0.4% glucose, 50 Jlg/ml of all 
amino acids, 50 Jlg/ml ampicillin, 40 Jlg/ml kanamycin, and 1 mM phosphate at 30°C 
overnight. The next day, these cultures were diluted 1/30 into minimal medium without 
phosphate and grown at 30°C until OD600 = 0.5. A portion of culture was shifted to 42°C 
and incubated for 30 min. Carrier-free [32p] orthophosphate was added at 500 JlCi/ml for 
5 min at 30°C. Cells were harvested by centrifugation and resuspended in sample buffer. 
Samples were boiled for 5 min and analyzed by electrophoresis on a 12.5% SDS-polyacry-
lamide gel. Lanes correspond to K38/pGPl-2/pT7-CDC7 at 30°C (a) and at 42°C (b), and 
K38/pGPl-2/pT7-7 at 30°C (c) and at 42°C (d). 
(B) Cells containing either pT7 -CDC7 or pT7 -7 were grown in M9CA medium at 30°C 
until OD600 = 0.5. A portion of culture was shifted to 42°C and incubated for 30 min. 
Cells were harvested and cellular extracts were prepared. In vitro phosphorylation was 
carried out for 30 min at 30°C in a buffer containing 25 mM Tris-HCI at pH 7.5,0.1 mM 
DTT, 10 mM MgCI2, and 1 JlM [y_32p] ATP. The reaction products were analyzed on a 
15% SDS-polyacrylamide gel. Lanes a (30°C) and b (42°C) show K38/pGPI-2/ 
pT7-CDC7, and c (30°C) and d (42°C) show K38/pGPI-2/pT7-7. The protein molecular 
weight markers are shown on the left of gels. 
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Figure 3. Autophosphorylation Assay on Nitrocellulose. 
Cellular extracts were made after heat induction. Proteins (50 J..Lg) were separated by 10% 
SDS-polyacrylamide gels and transferred to nitrocellulose. The filter was blocked with 5% 
nonfat dry milk in 25 mM Tris-HCI at pH 7.5. Proteins were denatured with 7 M 
guanidine-HCI in 50 mM Tris-HCI at pH 8.0, 50 mM DTT, 2 mM EDTA, and 0.25% 
nonfat dry milk for 1 hour at 25°C, and then allowed to renature in 50 mM Tris-HCI at pH 
7.5,100 mM NaCI, 2 mM DTT, 2 mM EDTA, 0.1% NP-40, and 0.25% nonfat dry milk 
for 16 hours at 4°C. The filter was treated with 5% nonfat dry milk in 25 mM Tris-HCI at 
pH 7.5 for 30 min at 25°C and then was incubated in the same condition with 0.01 J..LM 
[y_32p] ATP, 25 mM Tris-HCI at pH 7.5, 0.25% nonfat dry milk, and either 10 mM 
MgCI2, ZnCI2' MnC12, or CaCI2. After several washings with 25 mM Tris-HCl at pH 7.5 
and 0.25% nonfat dry milk at 25°C, the filter was dried and visualized by autoradiography. 
The data with Ca2+ are not shown. Lanes a, c, and e contain extracts from K38/ 
pGPl-2/pT7-CDC7 after heat induction. Lanes b, d, and f have extracts from K38/ 
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Figure 4. Exogenous Protein Phosphorylation with E. coli Extracts. 
E. coli extracts from strains K38/pGPI-2/p17-CDC7 or K38/pGPI-2/p17-7 were prepared 
and incubated for 30 min at 30°C with 1 jlM [y_32p] ATP, 10 mM MgCI2, 25 mM 
Tris-HCl at pH 7.5, and either 2 mg/ml casein (b,c), phosvitin (e,f), protamine (h,i), 
histone VI-S (k,l), or histone VIII-S (n,o) . As a control, casein (a), phosvitin (d), 
protamine (g), histone VI-S (j), or histone VIII-S (m) was treated as above except that E. 
coli extracts were omitted. Lanes b, e, h, k, and n contain extracts made from K38/ 
pGPI-2/pT7-CDC7. Lanes c, f, i, 1, and 0 have extracts from K38/pGPl-2/p17-7. The 
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Figure 5. Purification of the CDC7 Protein in DEAE-Cellulose Chromato-
graphy. 
The CDC7 protein was purified as described in Materials and Methods. After DEAE-cellu-
lose chromatography, the putative fractions containing the CDC7 protein were determined 
by scintillation counting, concentrated by acetone precipitation, and analyzed on 10% SDS-
polyacrylamide gels. Gels were treated with an autoradiography enhancer. Lane a contains 
fraction II and lanes b to t show the behavior of the CDC7 protein in DEAE-cellulose 
chromatography. Lanes b to t correspond to 80 to 250 mM NaCI in buffer A. The molecu-
lar weights of known proteins are shown on the left of the gel. 
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Figure 6. Purification of the CDC7 Protein on a Phosphocellulose Column. 
After DEAE-cellulose chromatography, fraction ill was concentrated by ammonium sulfate 
precipitation and applied to a column of PII phosphocellulose. The column was eluted 
with a NaCI step gradient consisted of 0.05,0.1, 0.2, 0.4, 0.6, and 1.0 M NaCl. Only 
fractions containing 0.05 (b), 0.6 (c), and 1.0 M NaCI (d) showed radioactivity high 
enough to be analyzed on SDS-polyacrylamide gels. Lane a contains fraction II. The gel 
was treated with an autoradiography enhancer. The molecular weight markers are shown 












Figure 7. Autophosphorylation Assay after DEAE-Cellulose Chromato-
graphy. 
(A) Extracts were prepared from pTI-CDC7 containing cells and fractionated on a column 
of DE52-cellulose as described in Materials and Methods. The volume of each fraction was 
8 ml and 1.5 ml of each fraction were used for scintillation counting. The remaining 6.5 ml 
were concentrated by acetone precipitation and analyzed on a 10% SDS-polyacrylamide 
gel. An autophosphorylation assay on nitrocellulose was carried out as explained in legend 
to Figure 3. Lane a contains fraction II and lanes b to 1 contain fractions from 50 to 250 
mM NaCI in buffer A after a 50-400 mM linear gradient. The numbers on the left indicate 
the molecular weights of known proteins. 
(B) All the steps in this experiment are the same as those in Figure 7A except that extracts 
were made from pTI -7 containing cells. Lane a contains fraction II and lanes b to k corre-
spond to fractions from 50 to 250 mM NaCI in buffer A. The molecular weights of known 
proteins are shown on the left of the gel. 
48 
A 











ab cdefgh k 
200-









Figure 8. Overproduction of the CDC7 protein upon Induction with IPTG 
of the tac promoter. 
Freshly transformed single colonies were used to inoculate cultures in LB medium in the 
presence of 50 Jlg/ml ampicillin. At OD600 = 004, IPTG was added to a final concentration 
of 1 mM. At the indicated times (in min) after IPTG induction, 0 .7 rn1 of samples were 
withdrawn immediately, cells centrifuged, and analyzed by electrophoresis on a 10% SDS-
polyacrylamide gel. The gel was stained with Coomasie blue; "p" indicates pKK223-3 
and "7" indicates pKK-CDC7. The numbers on the right are the molecular weights of 
known proteins. 
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The CDC7 Protein of Saccharomyces cerevisiae 
Is a Phosphoprotein that Contains Protein Kinase Activity 
[Published in Proceedings of National Academy of Science, USA (1991) 88,3574-3578.] 
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Abstract 
The CDC7 protein of Saccharomyces cerevisiae may be involved in the G liS phase 
transition and/or in the initiation of mitotic DNA synthesis. The CDC7 gene has two in-
frame AUG codons as possible translation start sites, which would produce 58 and 56 kDa 
proteins, respectively. Both p58 and p56 derived from recombinant plasmids complement 
the temperature sensitive growth defect of the cdc7-1 allele. To determine the biochemical 
function of the CDC7 protein, the CDC7 gene was cloned and polyclonal antibodies were 
produced against the CDC7 protein. CDC7 immune complexes prepared from yeast using 
these antibodies phosphorylate histone HI. Kinase activity is thermolabile in strains carry-
ing the cdc7-1 temperature sensitive mutant allele and is elevated more than 10-foid in 
strains carrying plasmids overexpressing either p56 or p58, confirming that the kinase in 
the immunoprecipitates is the CDC7 gene product. In addition we show that CDC7 is a 
phosphoprotein itself. Indirect immunofluorescence and biochemical fractionation show 
that the CDC7 protein is present at relatively high concentrations in the nucleus compared to 
the cytoplasm, suggesting that nuclear proteins may be substrates for the CDC7 protein. 
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Introduction 
Two major events define the eukaryotic cell cycle: replication of the chromosomes 
during S phase and segregation of the chromosomes during mitosis. Replication and seg-
regation are separated by two gap periods, Gland G2, during which the cells prepare for 
these events. There are also two major control points for the cell cycle in Gland G2, the 
point of commitment to DNA synthesis in G I and the regulation of progression into mitosis 
in G2. Although we have made great strides in understanding mitotic control in the last 
three years, relatively little is known about the events in G 1 that lead to S phase. In yeast, 
the point of commitment to DNA synthesis is defined as "START," early in Gl. DNA 
synthesis does not ensue immediately after START, however, and it is not clear whether 
the lag is due to assembly of the replication apparatus or to a cascade of controls initiated at 
START. CDC28, CDC4, and CDC7 define a dependent series of events set in motion at 
START (1-3). CDC28 encodes a protein kinase subunit, the analog of the highly con-
served cdc2/MPF kinase subunit involved in regulation of mitosis (3). CDC4 is homolo-
gous to one subunit of the signal transducing protein, transducin (4). The DNA sequence 
of the CDC7 gene predicts a protein which has homology to catalytic domains of the pro-
tein kinases CDC28/cdc2, NIMI, and a number of kinase-related transforming proteins 
(5). The CDC7 sequence differs from that of other protein kinases in the so-called 
phosphate acceptor domain, however (5,6). 
We have been interested in the role of CDC7 in the events linking START and the 
initiation of DNA replication. Mutations in CDC7 appear to block a precondition for DNA 
synthesis because cells carrying these lesions cannot start new rounds of DNA replication 
after a shift from permissive to nonpermissive temperature (7,8). The cdc7 mutation ar-
rests cells at the late Gl/S phase boundary, prior to the initiation of DNA synthesis and 
shows the dumbbell shaped terminal phenotype typically associated with a DNA synthesis 
or nuclear division defect (7,9). Cycloheximide does not inhibit initiation and completion 
of DNA synthesis when added after return of cdc7 cells fT?m the restrictive to the permis-
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sive temperature (10), suggesting that all protein synthesis late in G I essential for initiation 
of DNA replication can be completed during the cdc7 block. The phenotype of cdc7 mu-
tants would be consistent with CDC7 mediating an important signal for initiation of replica-
tion or with CDC7 participating in initiation itself. The function of the CDC7 protein in the 
G 1/S transition and/or in the initiation of mitotic DNA replication may be accomplished by 
its protein kinase activity, for instance, by periodically activating a crucial replication pro-
tein. This would imply that the function of CDC7 itself must be periodically regulated. 
Since overall levels of CDC7 RNA and protein do not seem to be limiting for entry into 
S phase (11), fluctuation in CDC7 levels does not account for its periodic function. Thus, 
either the activity of CDC7 itself must change during the cell cycle, or its location in the cell 
may vary, or there is a periodic change in a protein with which it interacts, for instance, a 
substrate. 
In order to investigate whether the activity of CDC7 changes during the cell cycle, 
we wished to define its biochemical activity and to devise an assay that could be used to 
follow CDC7 activity through the cell cycle. In this paper we show that the CDC7 protein 
contains protein kinase activity that can be measured specifically in nuclear extracts using 
histone HI as substrate. We also show that the CDC7 protein is modified by phosphoryla-
tion, and that it is located in the nucleus. 
Materials and Methods 
Strains 
Saccharomyces cerevisiae strains were SEY6210 (MATa his3-&OO /ys2-BOl 
trpl-tJ901 ural-52 suc2-tJ9/eu2-3,112) and YC7379 (MATaadel his7/ys2 tyrl ural-52 
cdc7-l) . Strain SEY6210 was obtained from S. D. Emr (California Institute of 
Technology, Pasadena, CA 91125) and strain YC7379 was constructed for this work. 
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Production of CDC7 Antisera 
The CDC7 gene was introduced into Escherichia coli using the ptac expression 
vector, pKK223-3 (12). Briefly, the gene was brought under the control of the tac pro-
moter by inserting the ClaIlEcoRI fragment from CDC7 into the EcoRl site of the vector, 
and reconstituting the CDC7 coding sequence with the oligonucleotide 5'-AA TIC ATG 
ACA AGC AAA ACG AAG AAT AT-3'. The protein was partially purified by chromato-
graphy on DEAE-cellulose (Whatman) and heparin-agarose columns. Bands correspond-
ing to the CDCl protein were excised from SDS-polyacrylamide gels and used for immu-
nization of two rabbits whose sera were free of anti-yeast IgG. Multiple injections were 
given until the CDCl protein was detected on immunoblots of yeast extracts. A 1:600 di-
lution of antibody is sufficient to detect 50 ng of CDCl protein by protein blotting. 
, 
Indirect Immunofluorescence of Yeast Cells 
This procedure is based upon the techniques developed by Kilmartin et a1. for 
whole mount yeast cells (13,14) and modified from the procedure as described previously 
(1S). 
Isolation of Yeast Nuclei 
Yeast nuclei were prepared by the method of Hurt et al. (16). The nuclear pellet 
was resuspended in SO ml of Percoll gradient buffer containing SO% Percoll (pharmacia), 
40 mM PIPES at pH 6.5, S mM MgC12, and 0.5 mM PMSF and centrifuged in a Beckman 
VTiSO rotor at 21,000 rpm for 40 min. Three bands were shown after centrifugation. The 
nuclear band was in the middle of the gradient and collected by inserting a needle into that 
position. The nuclear fraction was diluted with 3 vol of 40 mM PIPES at pH 6.S, S mM 
MgCI2, and 0.5 mM PMSF and centrifuged at 12,000 rpm for 20 min to remove Percoll. 
Immunoprecipitation and Protein Kinase Assays 
Nuclear fractions were prepared as above except the Percoll gradient step was not 
perfonned. Crude nuclei were resuspended in SO mM Tris-HCI at pH7.5, 10 mM MgC12, 
1 mM dithiothreitol, and 1 mM PMSF, and 4M (Nl4hS04 was added to 0.4 M final 
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concentration. The lysate was spun at 100,000 g for 30 min. The supernatant was 
precipitated with ammonium sulfate (70% saturation) and centrifuged at 100,000 g for 20 
min. The pellet was dissolved in 3 mlof 15% (w/v) sucrose, 50 mM Tris-HCI at pH 7.5, 
50 mM NaCI, 0.1% Triton X-l00, 1 mM dithiothreitol, and 0.5 mM PMSF, dialyzed 
against the same buffer, and frozen in a1iquots at -70°C until needed. Immunoprecipitations 
and protein kinase assays were performed as described by Reed et al. (3) with some 
modifications. Ten JlI of pre immune serum was added to 20 JlI of a protein A-Sepharose 
(100 mg/rnl) suspension and incubated for 1 hr at 4°C. The beads were collected by 
centrifugation and resuspended with 0.5 mg of cytosolic or nuclear fractions from various 
yeast cultures. After 1 hr at 4°C, the suspension was centrifuged and the supernatant was 
transferred to a new tube. The pellet contained preimmune complexes and was saved for 
further assays. The supernatant was used for a second immunoprecipitation with 10 JlI of 
CDCl antisera. Then, the preimmune and CDCl immune complexes were washed twice in 
50 mM Tris-HCI at pH 7.5, 150 mM NaC!, 0.5% Tween 20, and 0.2 mM EDTA, 
followed by two washes in 0.5 M LiCI, and 0.1 M Tris-HCI at pH 7.5, and finally by two 
washes with 25 mM Tris-HCI at pH 7.5,5 mM NaP, 10 mM MgCh, 0.1 mM EGTA, and 
0.5 mM PMSF (reaction buffer). The beads were resuspended in 30 JlI of the reaction 
buffer. For kinase assays, 2 Jlg of histone HI (Boehringer Mannheim Biochemicals) was 
added to 30 JlI of redissolved immunoprecipitates along with 300 JlM [y_32p]ATP 
(0.3 JlCiinmol). After 15 min at 37°C, reactions were terminated by the addition of SDS 




Overexpression of CDC7 in Yeast 
The CDC7 gene was isolated by transfonnation of a ura3-52 cdc7-l strain of 
S. cerevisiae with a YCp50 yeast genomic library constructed in this laboratory (17). To 
define the catalytic activity of the CDC7 protein, we used the cloned gene to facilitate 
isolation of the CDC7 protein from E. coli and yeast. The CDC7 protein expressed in 
E. coli using three different expression systems was not active as a protein kinase with any 
substrates tested (data not shown). Since we were unable to demonstrate CDC7 kinase 
activity in E. coli, we reasoned that there might be a specific modification of the protein or a 
specific cofactor only found in yeast. Therefore, we next undertook to isolate the protein 
from yeast. For this purpose, we cloned CDC7 in a GALlO expression vector. The 
nucleotide sequence of CDC7 contains two in-frame ATG codons, one at nucleotide 1 and 
the other at nucleotide 55. The gene product arising from the first ATG in CDC7 is called 
p58, and the one from its second A TG is called p56. Since it is not known which ATG is 
used in vivo, we produced both p58 and p56. The entire CDC7 gene was inserted into the 
unique EcoRI site of the GAL expression vector, pSEY18-Gal (S. D. Emr, California 
Institute of Technology, Pasadena, CA 91125), a high copy number vector that allows 
inducible expression of the CDC7 protein. The fragment carrying the CDC7 gene was 
created by ligation of a synthetic linker (EcoRl-ATG ACA AGC AAA ACG AAG AAT-
CIa!), representing the first seven amino acids of CDC7, to the 2.4 kb ClaI-EcoRl fragment 
of CDC7. In order to express p56, the first ATG was removed by cutting at the ClaI site, 
which lies between the two initiation codons, followed by further deletion with Bal31 of 
the DNA between that ClaI site and the second ATG. The plasmids encoding p58 and p56 
were named pSYC758 and pSYC756, respectively. Both plasmids were able to 
complement the mitotic growth defect in cdc7-l cells at the nonpermissive temperature. 
CDC7 protein expressed from these plasmids was analyzed by protein blotting and 
immunoprecipitation of 35S-labeled yeast cells. As shown in Figure 1, yeast strains carry-, 
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ing pSYC758 and pSYC756 produced CDC7-encoded proteins of 58 and 56 kDa, respec-
tively. Strong signals were obtained only after galactose induction (lanes e, f and h). 
Thus, the CDC7 protein may be present at very low levels in wild-type cells. 
Protein Kinase Activity of the CDC7 Gene Product Isolated from Yeast 
Because of the low levels of CDC7 protein present in whole cell extracts of wild-
type cells and because the overproduced protein was difficult to solubilize, conventional 
purification was inefficient. CDC7 protein was therefore immunoprecipitated from both 
nuclear and cytosolic fractions of various yeast strains, and the redissolved immunoprecipi-
tates were used in protein kinase assays employing calf thymus histone HI as a substrate. 
As shown in Figure 2, histone HI is clearly phosphorylated by immunoprecipitates pre-
pared from nuclear extracts with CDC7 antisera, suggesting that the CDC7 protein contains 
protein kinase activity. 
Since in order to preserve enzymatic activity, immunoprecipitates must be prepared 
under conditions where additional proteins may coprecipitate (although we removed pro-
teins interacting nonspecifically with the rabbit IgG by IlTst precipitating with preimmune 
sera), to insure that the kinase activity observed was due to the CDC7-encoded protein and 
not to a contaminating kinase, two controls were carried out. First, we demonstrated over~ 
production of kinase activity in extracts of cdc7-1 mutant strains carrying plasmids 
pSYC758 and pSYC756 compared to extracts of the same strain carrying vector alone. 
Comparison of lanes c, d and e in Figure 2 indicates that the level of kinase activity was 
over 100foid higher in the CDC7 overproducer than in a strain containing vector alone. The 
magnitude of overproduction was estimated from four independent experiments and densit-
ometer tracings of the autoradiograms. Since these assays measure extents of phospho-
rylation rather than initial rates, this is a minimum estimate of the actual overproduction. 
Second, we demonstrated that the kinase activity was thermolabile in irnmunoprecipitates 
prepared from cdc7-1 mutants. Comparison of lanes band c in Figure 2 shows that the 
kinase activity is thermolabile in the strain carrying vector alone (c8l=o.2). Conversely, in 
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the same strains carrying CDC7-containing plasmids, kinase activity at 37°C is at least 
2-fold higher than at 23°C [lanes f and g, (Qi~=2)], indicating that the thermolability ob-
served in lanes b and c is not due to nonspecific factors in the strain background affecting 
kinase activity at 37°C vs. 23°C and that the kinase is associated with the CDC7 gene prod-
uct. We could not detect CDC7-dependent phosphorylation of histones with preimmune 
complexes (data not shown). 
CDC7 Is a Phosphoprotein 
In immunoprecipitates from strains overproducing p58 and p56, in addition to 
phosphorylation of histone HI, a protein of 58 or 56 kDa, respectively, was also phospho-
rylated. As shown in Figure 3, phosphorylation of these 56 and 58 kDa proteins was de-
tectable only in nuclear and not in cytoplasmic extracts. It is likely that these proteins are 
the CDC7 gene product. The 48 kDa band that appears in this experiment was also seen in 
immunoprecipitates prepared with preserum and may represent a contaminant (such as 
IgG), or it may be an activator or a substrate of CDC7. 
The observed phosphorylation of p56 and p58 by the CDC7 immunoprecipitates 
could be due either to autophosphorylation or to a coprecipitating kinase. The results sug-
gested, however, that CDC7 might occur in vivo as a phosphoprotein. To investigate the 
latter possibility, cells carrying pSYC758 were grown on galactose, labeled with 32pj, and 
immunoprecipitated with CDC7 antisera. As shown in Figure 3 (lane i), strains overpro-
ducing p58 do contain a 58 kDa phosphoprotein. This protein is not observed in the ab-
sence of overproduction (lane j) or in extracts precipitated with preimmune serum (lane k). 
Localization of the CDC7 Gene Product by Indirect Immunofluorescence 
and Subcellular Fractionation 
Knowledge of the subcellular localization of the CDC7 protein may be useful in es-
tablishing its molecular function by narrowing the range of potential substrates and cellular 
proteins with which it interacts. Using indirect immunofluorescence microscopy with 
CDC7 antisera, we found intense immunofluorescence in the nuclei of CDC7-Qverproduc-
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ing cells (Figure 4A). Fainter, but distinct immunofluorescence was also seen in the cyto-
plasm. In the experiment shown, cells were also stained with Hoechst 33258 to verify the 
position of the nuclei (Figure 4B). However, identical staining patterns were observed in 
other experiments where only anti-CDC7 staining and Nomarsky were used, and therefore 
the patterns are not due to leakage from the additional dye. Thus, the CDC7 protein ap-
pears to be present in both the cytoplasm and nucleus but to be relatively concentrated in the 
nucleus. Only faint CDC7-specific immunofluorescence was detected when cells carrying 
the vector pSEYI8-Gal were stained with CDC7 antisera in an identical manner (data not 
shown). The difficulty in visualizing CDC7 antigen in the absence of overproduction sug-
gests that the levels of CDC7 protein in yeast are low, in accord with the immunoblot anal-
ysis (Figure I, lanes a and d). 
The nuclear localization of the CDC7 protein was corroborated by biochemical frac-
tionation. Figure 5 shows immunoblot analysis of CDC7 protein in cytosolic and nuclear 
fractions. Equal amounts of protein, rather than equal numbers of cell equivalents, were 
loaded in each lane, because of the difficulty of quantitating cell equivalents that are due to 
uncertainty in measurement of losses experienced during the purification of nuclei. These 
results demonstrate, however, that CDC7 is relatively concentrated in the Percoll gradient 
purified nuclei. When 5-fold excess of cytosolic protein is analyzed, CDC7 is detectable 
(not shown). We estimate that both p58 and p56 were present in at least 20-fold higher 
concentration in nuclear fractions than in cytosolic fractions (Figure 5). ABFI and SSBI, 
nuclear proteins previously studied in this laboratory (18,19), were also observed in our 
nuclear fractions only (data not shown). Comparison of the CDC7 sequence with the 
nuclear targeting signal consensus revealed putative nuclear localization signals in at least 
six different positions. 
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Discussion 
The phenotype of S. cerevisiae cdc7 mutants suggests that the CDC7 gene product 
has multiple functions. CDC7 may be involved in the initiation of mitotic DNA synthesis, 
premeiotic recombination, formation of ascospores, and error-prone DNA repair (20,21). 
To date, however, the molecular roles of CDC7 in those events have not been character-
ized. As a step toward investigating the functions of CDC7 in yeast, we have identified the 
CDC7 protein as a protein kinase in vegetatively growing yeast cells. [While our work was 
in review, a similar result was presented by others (22), although kinase activity could only 
be observed after overproduction.] We have also shown that the CDC7 protein is phos-
phorylated in vivo and is found in the nucleus as well as in the cytoplasm. The demonstra-
tion of protein kinase activity in the CDC7 protein is consistent with preliminary experi-
ments showing that in vitro transcription and translation of the CDC7 gene produces a pro-
tein kinase activity (23). CDC7 appears to be present at low abundance in yeast as pre-
dicted from the codon utilization analysis of the CDC7 open reading frame. We have, 
however, found a very faint band of p58 in immunoblots performed with nuclear extracts 
of wild-type yeast strains when alkaline phosphatase conjugates were used to visualize the 
CDC7 protein (unpublished data). 
As suggested by the amino acid sequence, the CDC7 protein seems to carry a pro-
tein kinase activity. Using exogenous histone HI as a substrate, we demonstrated protein 
kinase activity in CDC7 immunoprecipitates of nuclear extracts of wild-type cells without 
overproduction. The histone phosphorylation was thermolabile in cdc7-1 extracts and 
phosphorylation was proportional to the amount of p58 present. Elevated kinase levels in 
the strain overproducing p56 suggest that p56, as well as p58, is active as a kinase. In 
addition to acting as protein kinases, both p56 and p58 also appear to be substrates of a 
phosphorylating activity in the immunoprecipitates. It is not yet clear if this represents 
autophosphorylation or coprecipitation of another kinase. Our finding that CDC7 protein is 
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a phosphoprotein in vivo, suggests that the in vitro phosphorylation may be physiologically 
significant. 
According to indirect immunofluorescence and subcellular fractionation studies, 
both forms of CDC7 are concentrated in the nuclei of CDC7 -overproducing cells. We are 
not sure whether the staining patterns reflect a role for CDC7 in both the cytoplasm and 
nucleus or if they simply result from the delocalization of the exclusively nuclear protein 
that is due to overproduction. The demonstration that CDC7 is associated with the nuclei 
of mitotic cells suggests that CDC7 may function in the mitotic cell cycle by 
phosphorylating proteins involved in the initiation of DNA synthesis and/or in the Gl/S 
phase transition. 
Although basal level expression requires an element in the promoter that is homolo-
gous to a c-fos activating sequence, CDC7 mRNA remains at a constant level throughout 
the cell cycle when measured in cells released from a-factor arrest (11,24). Furthermore, 
indirect evidence suggests that the CDC7 protein exists in excess of the amount required for 
a single mitotic cell division (11). Yet CDC7 is required at a discrete point in the cycle. It 
will be of interest to investigate whether phosphorylation of CDC7 protein, translocation to 
the nucleus, catalytic activity of the CDC7 protein kinase and/or availability of a crucial 
substrate is regulated through the cell cycle. 
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Figure 1. Characterization of CDC7 antibody by immunoblot and immuno-
preci pitation. 
(Left) Stationary cultures of yeast strain SEY621O/pGI2/pSEYI8-Gal (lanes a and d), and 
the CDC7-overproducing strains SEY621O/pGI2/pSYC756 (lanes b and e), and 
( 
SEY6210/pGI2/pSYC758 (lanes c and f) grown in synthetic complete (SC) medium 
(minus uracil and leucine) plus 2% glucose were diluted 1:10 in SC medium (minus uracil 
and leucine) containing either 2% glucose (lanes a, b, and c) or 2% galactose (lanes d, e, 
and f). Plasmid pG 12 provides the GAIA protein essential for expression from the GALlO 
promoter (25). After 8 hrs at 30°C, whole yeast lysates were prepared by disruption of the 
cells with glass beads and clarified by centrifugation. The pellets were resuspended in 
buffer containing 1% SDS and analyzed on a 10% SDS-polyacrylarnide gel. Proteins were 
then electroblotted to a nitrocellulose membrane. This immunoblot was stained with anti-
CDC7 antisera at a dilution of 1:250, and visualized by using the Bio-Rad ImmunBlot as-
say kit (goat anti-rabbit IgG horseradish peroxidase conjugate). 
(Right) For labeling with [35S]methionine (Trans 35S-label, ICN), strain 
SEY621O/pGI2/pSYC758 was grown in SC medium (minus uracil, leucine, and methio-
nine) plus 2% glucose, to 2 x 107 cells/mi. Cells were harvested, washed twice and resus-
pended in the same medium containing 2% galactose. After 1 hr at 300C, 250 JlCi of [35S] 
methionine was added and incubation continued for 40 min. Cells were lysed in 100 Jll of 
50 mM Tris-HCI at pH 7.5,1 mM EDTA, and 1% SDS by vortexing in the presence of 
glass beads followed by boiling for 5 min. The lysate was diluted by the addition of 1 mi 
of buffer (50 mM Tris-HCI at pH 7.5, 150 mM NaCI, 0.1 mM EDTA, and 0.5% 
Tween 20), centrifuged, and the supernatant was used for immunoprecipitation with 5 JlI 
of preimmune sera (lane g) or 5 JlI of CDC7 antisera (lane h). Samples were analyzed by 
electrophoresis in 10% SDS-polyacrylarnide. 
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Figure 2. CDC7-dependent phosphorylation of histone HI. 
Nuclear extracts were prepared from strain YCl379 (cdc7-l) , carrying pSEYI8-Gal, 
pSYC756, or pSYCl58. Cells were grown at 23°C and proteins (0.5 mg) were immuno-
precipitated twice: proteins interacting nonspecifically with the rabbit IgG were removed by 
precipitating with preimmune sera and the supernatant was subjected to a second immuno-
precipitation with CDCl immune sera. The final pellet was pre incubated at 23°C (lanes b 
and f) and 37°C (lanes a, c, d, e, and g). After 30 min, 2 Ilg of histone HI and 300 IlM 
[y_32p] ATP were added and incubation continued for 15 min. Reaction products were 
analyzed on a 10% SDS-polyacrylamide gel, stained with Coomassie blue, dried, and auto-
radiographed. Lane a, histone HI alone; lane b, YC7379/pSEYI8-Gal, 23°C; lane c, 
YCl379/pSEYI8-Gal, 37°C; lane d, YC7379/pSYC756, 37°C; lane e, YCl379/pSYCl58, 
37°C; lane f, YCl379/pSYC758, 23°C; lane g, YCl379/pSYCl58, 37°C. 
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Figure 3. Phosphorylation of the CDC7 protein in vivo and in vitro. 
(Left) Proteins (0.5 mg) of nuclear (lanes a·d) and cytosolic (lanes e-h) fractions were 
immunoprecipitated twice as in Figure 2 and incubated for 30 min at 37°C in the presence 
of 10 IlCi of [y..32p] ATP (3000 Ci/mmol; Amersham). Samples were analyzed on a 10% 
SDS-polyacrylamide gel. Lanes a and e, SEY621O/pG12/pSYC758; lanes band f, 
SEY6210/pG12/pSYC756; lanes c and g, SEY621O/pG12/pSEY18-Gal; lanes d and h, 
YC7379/pSEY18-Gal. 
(Right) 32P-Iabeled CDC7 immunoprecipitates were prepared as follows. 5 x 107 cells of 
strain SEY621O/pG12/pSEY18-Gal (lane j) or SEY621O/pG12/pSYC758 (lanes i and k) 
were labeled for 1 hr with 0.5 mCi of [32p] orthophosphate (New England Nuclear) in re-
duced phosphate minimal medium (26) containing 2% galactose. Cell lysis and immuno-
precipitation were performed as described in the legend to Figure 1 except that either 10 III 
of preimmune sera (lane k) or 10 III of CDC7 immune sera (lanes i and j) were used. 
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Figure 4. Subcellular localization of the CDC7 protein. 
Yeast strain SEY621O/pGI2/pSYC758 was grown to stationary phase in SC medium 
(minus uracil and leucine) plus 2% glucose. Cells were harvested, washed twice with SC 
medium (minus uracil and leucine) containing 2% galactose, and resuspended in the same 
medium. At OD600=O.4, cells were fixed with formaldehyde, digested with 
J3-glucuronidase and zymolyase lOOT, immobilized on polylysine coated slides, and 
stained with polycIonal anti-CDC7 antiserum (A) and Hoechst 33258 (B). (A) Viewed 
under rhodamine excitation wavelength. (B) Yeast nuclei were visualized by staining with 




Figure 5. Localization of CDC7 by subcellular fractionation. 
Proteins (100 j.l.g) of nuclear (lanes a-d) and cytosolic (lanes e-h) fractions were separated 
by a 10% SDS-polyacrylamide gel, electroblotted to nitrocellulose, and stained with anti-
CDC7 antiserum (diluted 1:250). Arrows on the left indicate the immunoblot bands for 
COC7-p58 and CDC7-p56, respectively. Lanes a and e, SEY621O/pG12/pSYC758; lanes 
band f, SEY621O/pG12/pSYC756; lanes c and g, SEY621O/pGl2/pSEYI8-Gal; lanes d 
and h, YC7379/pSEY18-Gal. 
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CHAPTER IV 
A Possible Phosphorylation Cascade Operating Between the 
Commitment to, and Initiation of DNA Replication Involving 
Yeast CDC28, CDC7, and the Replication Protein, RP-A 
(Submitted in Cell for publication in 1991) 
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Abstract 
The yeast Cdc7 function is required for the G liS transition and is dependent on 
passage through START, a point controlled by the Cdc28 protein kinase. CDC7 encodes a 
protein kinase and we show that Cdc7 kinase activity but not abundance varies in the cell 
cycle. We present several lines of evidence that activation of Cdc7 kinase is at least in part 
through a phosphorylation mechanism which involves Cdc28. We hypothesize that Cdc7 
may lead to the initiation of DNA synthesis and S phase by phosphorylating one or more 
DNA replication proteins. A likely candidate is the single-stranded DNA binding protein, 
replication protein A, RP-A, because it is phosphorylated specifically late in G 1. We pre-
sent evidence that both Cdc28 and Cdc7 kinases participate in this phosphorylation. 
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Introduction 
The eukaryotic cell cycle is composed of two major events, S phase, during which 
the chromosomes are replicated, and M phase, during which the chromosomes are segre-
gated. These two portions of the cycle are separated by gaps called G I and G2, which are 
devoted to regulating the transitions between replication and segregation. During G 1, the 
events leading to chromosome duplication are monitored and executed. Checkpoints ensur-
ing completion of DNA synthesis and readiness for nuclear division occur in G2 (Hartwell 
and Weinert, 1989). In the past few years, significant breakthroughs have been made in 
determining the molecular events that regulate and promote entry into M phase (Dunphy 
and Newport, 1988a; Lewin, 1990). A key regulatory molecule in this process is highly 
conserved in eukaryotes, namely, the p34/cdc2+/MPF (mitosis promoting factor) protein 
kinase subunit (Dunphy and Newport, 1989b). Since much less is known about the events 
leading to the initiation of nuclear DNA replication at the G lIS transition, we have under-
taken studies of this phase of the cell cycle. 
In unicellular organisms such as yeast (Saccharomyces cerevisiae, 
Schizosaccharomyces pombe), the major control point in G I is called START, which may 
or may not correspond to the "restriction point" in mammalian cells (pardee, 1989; Pringle 
and Hartwell, 1981). START defines the point in the cycle after which the cell is conunit-
ted to a round of DNA synthesis and no longer can undergo the alternative developmental 
program of conjugation. Several yeast mutants, the best studied of which is cdc28, arrest 
at a point in G 1 at which conjugation is still possible and thus are said to affect START 
(Pringle and Hartwell, 1981; Reed, 1980). CDC28 encodes the homolog of the 
p34/cdc2+/MPF protein kinase subunit. Thus, it appears that the same protein kinase is in-
volved in regulating both the G lIS and G2/M transitions during the yeast cell cycle (Ghiara 
et aI., 1991; Nurse and Bissett, 1981; Piggott et al., 1982; Surana et al., 1991). 
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We have very little infonnation on the molecular nature of the events set in motion 
by CDC28 and the other START genes. While the commitment to DNA synthesis is made 
by passage through START, DNA synthesis does not begin immediately. A number of 
additional genetically defined steps must occur before the onset of DNA replication. It is 
likely that both induction of the genes encoding replication proteins and post-translational 
activation of replication proteins are preconditions for the initiation of DNA synthesis. The 
CDC28, CDC4 and CDC7 genes are thought to define one series of steps that must be 
completed before the initiation of DNA synthesis (Hartwell, 1976; Pringle and Hartwell, 
1981). CDC28 encodes a protein kinase, CDC4 encodes a protein with homology to the 
f3-subunit of transducin and the ets oncogene (Fong et al., 1986; Peterson et aI., 1984) and 
CDC7 encodes a protein kinase (Patterson et aI., 1986; Hollingsworth and Sclafani, 1990; 
Y oon and Campbell, 1991). Though these activities suggest a signal transduction cascade, 
little information is available about their functional interrelationships. 
Our focus has been to detennine the biochemical basis for the position of the Cdc7 
protein in the putative 01 regulatory cascade. The CDC7 controlled events have been 
shown genetically to depend on completion of START, since the CDC7 step cannot be 
completed during block of cells with the mating pheromone a-factor, which like cdc28 
mutations, arrests cells at START (Hereford and Hartwell, 1974). The Cdc7 protein is 
thought to execute its function late in 01, since cells carrying a thermosensitive (ts) cdc7 
mutation arrest mitotic growth at the 01/S phase boundary at the restrictive temperature, 
just before the initiation of DNA synthesis (Hartwell,1973; 1976). These cells show a 
dumbbell shaped terminal phenotype typically associated with a DNA synthesis or nuclear 
division defect (Hartwell, 1973). Another reason for placing CDC7 function very late in 
01 is the fact that cdc28 and cdc4 mutants blocked at the nonpermissive temperature and 
then retumed to the permissive temperature in the presence of the protein synthesis inhibitor 
cycloheximide, they do not progress further through the cycle and do not enter S phase, 
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while cdc7 mutants treated in the same way enter S phase and complete DNA synthesis in 
the presence of protein synthesis inhibitors (Hereford and Hartwell, 1974). Further protein 
synthesis is thus necessary for the initiation of DNA synthesis after CDC28 and CDC4, 
whereas all of the proteins essential for DNA replication appear to be present at the CDC7 
stage. Which crucial proteins are needed is not known, but the cyclins are likely to be 
among them (Wittenberg et al., 1990). CDC7 thus mimics the final stage of the "restriction 
point" in mammalian cells, insofar as it was defined as the point in the cell cycle after which 
no further protein synthesis is necessary for initiation of DNA synthesis. Evidence sug-
gesting the presence of Cdc7 protein in a putative DNA replication complex has been pre-
sented (Jazwinski, 1988). 
In contrast to this behavior during mitosis, diploid homozygous cdc7-ts cells initiate 
premeiotic DNA synthesis normally at the restrictive temperature. However, these diploids 
do not form a synaptonemal complex, nor do they commit to recombination or form 
ascospores, indicating that the cdc71esion affects the mitotic and meiotic pathways in a dif-
ferent, distinct manner (Schild and Byers, 1978). Furthermore, the CDC7 gene has also 
been implicated in an error-prone DNA repair pathway as a member of the RAD6 epistasis 
group (Njagi and Kilbey, 1982). Finally, CDC7 may also be involved in transcriptional 
silencing of the HMR mating type cassette (Axelrod and Rine, 1991). 
At present, little is known about how CDC7 affects these different DNA processes. 
A clue as to the molecular function of CDC7 was afforded by the demonstration that the 
open reading frame encoding CDC7 contains the 11 catalytic domains characteristic of 
protein kinases (Patterson et aI., 1986). We and others have shown that the Cdc7 protein 
isolated from vegetatively growing yeast cells is active as a kinase that phosphorylates 
histone HI in vitro (Hollingsworth and Sclafani, 1990; Yoon and Campbell, 1991). In 
addition, the Cdc7 protein is modified by phosphorylation and is located in the nucleus 
(Y oon and Campbell, 1991). The demonstration that Cdc7 is a protein kinase associated 
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with the nuclei of mitotic cells suggests that Cdc7 may function in the mitotic cell cycle by 
phosphorylating proteins involved in the initiation of DNA synthesis and/or in the G l/S 
transition. Recently, Din et at. (1990) have shown that both CDC28 and CDC7 are re-
quired in vivo for phosphorylation of the 34 kDa subunit of the replication protein RP-A, 
and that this phosphorylation occurs at the G l/S transition. RP-A was originally isolated 
from human cells in the process of fractionating cellular extracts into components capable 
of reconstituting SV40 DNA replication in vitro (Fairman and Stillman, 1988; Wobbe et 
al., 1987; Wold and Kelly, 1988). RP-A is an SSB essential for both the initiation and 
elongation reactions (Wold and Kelly, 1988; Kenny et al., 1989;1990). Because of its doc-
umented cell cycle specific phosphorylation pattern, RP-A is a good candidate for direct 
phosphorylation by either the Cdc28 or Cdc7 kinase, and in this paper we show that both 
kinases do indeed phosphorylate RP-A in vitro. 
Although we had some clues to the role of CDC7 from previous work, very few 
clues were available as to what limits CDC7 function to a specific point in the cell cycle. 
CDC7 is not periodically transcribed, and cells carrying a deletion of CDCl on the chromo-
some can divide up to eight times after loss of a plasmid carrying the CDC7 gene (Sclafani 
et al., 1988). Thus periodic activation of Cdc7 kinase rather than abundance may govern 
its stage-specific function. Since Cdc7 appears to be required only for the final stage of the 
G 1/S transition, we speculated that the catalytic activity of the Cdc7 kinase might be regu-
lated by Cdc28 as part of a cascade linking START and the onset of DNA synthesis. In 
this paper we present evidence to support this proposal. First, we demonstrate that Cdc7 
activity, not Cdc7 protein levels vary during the cell cycle. Second, we show that phos-
phorylation of Cdc7 protein is required for its activity. Cdc28 kinase specifically phospho-
rylates the Cdc7 protein and activates Cdc7 kinase. To complement the biochemical data, 
we show that CDC7 hyperexpression suppresses the temperature sensitive phenotype of a 
cdc28-13 mutation at 33°C. We propose that, taken together with numerous preceding 
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genetic results, these biochemical studies on Cdc7, Cdc28 and RP-A define a pathway 
through S phase linking START and initiation of DNA replication. 
Results 
The Activity of Cdc7 Kinase Varies in the Cell Cycle and Is Dependent on 
Cdc28 Function 
We have shown previously that the Cdc7 protein prepared as an immune complex 
from nuclear extracts of vegetatively growing cells, contains a histone HI kinase activity 
(Yoon and Campbell, 1991). Genetic studies, however, suggest that Cdc7 is not active 
throughout the entire cell cycle, but that it functions in vivo only after completion of 
START. Demonstration by Sclafani et al. (1988) that CDC7 is not periodically transcribed 
and that there appears to be sufficient Cdc7 in the cell to support eight cell cycles, indirectly 
suggested that fluctuation in abundance of Cdc7 does not account for its periodic activity. 
In order to directly investigate the levels of Cdc7 protein and kinase at different stages of 
the cell cycle, the activity and abundance of Cdc7 were determined in extracts of synchro-
nized cells. A standard a-factor block and release protocol was followed. As shown in 
Figure I, Cdc7 activity, as measured by ability of Cdc7 immune complexes to phospho-
rylate histone HI, is low in a-factor arrested cells. After removal of a-factor, Cdc7 kinase 
activity increases during Gland remains high throughout the rest of the cell cycle. Activity 
then drops sharply, at a position when cells with large buds are maximal, near the end of 
the first cell cycle. In the second cell cycle after release from a-factor, activity rises again 
late in G 1. Thus, Cdc7 activity varies in the second cell cycle with a timing consistent with 
its function in late G I. The first cell cycle is also consistent, but the first cell cycle after 
a-factor release is known to be atypical, and the second cell cycle is a better indicator of cell 
cycle timing. The activity levels are clearly not determined by the abundance of Cdc7 pro-
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tein, however, since the levels of Cdc7 protein, as measured by Western blotting, remain 
constant in all samples (Figure 1). 
In order to precisely define the timing of Cdc7 kinase appearance, we measured 
Cdc7 kinase activity in immunoprecipitates of nuclear extracts of cells arrested at various 
stages in the cell cycle either by use of cdc mutants or by the use of cell cycle specific in-
hibitors. Yeast cells were blocked with the mating pheromone a-factor, hydroxyurea, or 
nocodazole, which inhibit START, DNA synthesis and mitosis, respectively. In addition, 
cells were arrested at the cdc28, cdc4, and poll steps, which represent START, Gl, and 
S phase, respectively. As shown in Figure 2, there was no active Cdc7 kinase in cdc28 
blocked cells and greatly reduced, though detectable, levels in a-factor arrested cells 
(Figure 2, lanes 2 and 6). 
In contrast, cells blocked at the cdc4 step and beyond in the cycle, even the nocoda-
zole treated cells, contained active Cdc7 kinase (Figure 2, lanes 3, 4, 7 and 8). When 
cdc28 cells were grown at the permissive temperature, 25°C, and assayed for kinase activ-
ity, normal levels of kinase were observed as shown in Figure 2, lane 5. These findings 
suggest that the Cdc7 kinase is inactive before START, but that passage through START 
provides a kinase active at least in vitro. Since substrate was provided in the in vitro assay, 
availability of substrate could not account for the inactivity of Cdc7 in the extracts, although 
such secondary factors may contribute to the overall regulation of G 1 in vivo. Thus, we 
favored the interpretation that activation of the Cdc7 kinase through post-translational mod-
ification during the cycle was an important component of its cell cycle regulation, and 
sought more direct evidence that this might be the case. 
The Activity of Cdc7 Protein Is Correlated with Changes in 
Phosphorylation 
The fact that Cdc7 was active at all arrest points except Gl/START, even in cdc4 
arrested cells, suggested to us that CDC7 might be more intimately connected to START 
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than had been appreciated from interpretation of genetic experiments using reciprocal shifts 
and double mutants to order the function of the G 1 CDC genes (Hereford and Hartwell, 
1974). We became particularly interested in whether Cdc28 might directly activate the 
Cdc7 kinase, that is, whether Cdc7 kinase might be one of the crucial substrates of the 
Cdc28 kinase. We have previously reported that Cdc7 is a phosphoprotein and that this 
phosphorylation can be detected by in vivo 32p; labeling of cells expressing elevated levels 
of Cdc7 protein (Yoon and Campbell, 1991). To determine whether the absence ofCdc7 
kinase activity correlates with absence of phosphorylation, we carried out blocking experi-
ments similar to those in Figure 2 and characterized the phosphorylation state of Cdc7 dur-
ing the block. cdc28, cdc4, cdc6, and poll strains were transformed with a plasmid ex-
pressing CDC7 under control of the GALl ,1 0 promoter and were labeled with 32p; in vivo 
during a block at the nonpermissive temperature. [cdc6 arrests late in G 1 with a phenotype 
similar to cdc7 (Hartwell, 1976).] As shown in Figure 3, Cdc7 was present as a phospho-
protein in all except cdc28 blocked cells (lanes 2-5). cdc28 mutant cells grown and labeled 
at 25°C did contain a phosphorylated band of Cdc7 (Figure 3, lane 1). Thus, there is a 
positive correlation between when the kinase is active and the phosphorylation state of 
Cdc7 protein (Figures 2 and 3). These results also show that the kinase that phospho-
rylates Cdc7 is not limiting and can phosphorylate the Cdc7 protein present in cells 
expressing elevated levels of Cdc7 protein. This is consistent with the fluctuation in Cdc7 
activity during the cell cycle even when Cdc7 is overproduced (Figure 1) and the viability 
of cells overproducing Cdc7 (y oon and Campbell, 1991). 
Phosphatase Treated Cdc7 Immune Complexes Are Inactive as Histone H1 
Kinase 
The positive correlation between the extracts in which Cdc7 protein is maximally 
phosphorylated and in which it is active predicted that phosphorylation might be essential 
for activity of the Cdc7 kinase. The histone HI kinase activity of Cdc7 was therefore 
85 
monitored after incubating Cdc7 immune complexes in the presence or absence of phos-
phatase (Figure 4A). For these experiments we used immune complexes prepared from 
cells overproducing native Cdc7 protein by incubation with Cdc7 antibody (Figure 4A, 
lanes 1-3). We also prepared a Cdc7-hemagglutinin fusion protein and overproduced it in 
yeast as described in Experimental Procedures. Cdc7-containing immune complexes were 
then prepared with the hemagglutinin monoclonal antibody, 12-CA5, which recognizes the 
hemagglutinin epitope (Figure 4A, lanes 4-7). The Cdc7 protein immunoprecipitated by 
the two antibodies was active as a histone HI kinase (Figure 4A, lanes I and 4). Upon 
phosphatase treatment, however, Cdc7 was inactivated as a kinase, as shown in Figure 4A, 
lanes 2, 3, and 5. The amount of Cdc7 protein remained constant under the conditions of 
the phosphatase treatment (Figure 4B), assuring that the inactivation was not due to prote-
olysis. Although phosphatase was removed by extensive washing before assaying for 
kinase, two experiments were performed to ensure that there was no residual phosphatase 
bound tightly to the protein A-Sepharose beads, which might interfere with the Cdc7 
kinase. In Figure 4A, lane 6, a combined sample of both phosphatase-treated (1/2) and 
untreated (1/2) immune complexes is seen to contain about one half of the kinase activity of 
that shown in Figure 4A, lane 4, conftrming that phosphatase was not dephosphorylating 
histone HI during the kinase reaction. In a separate experiment, okadaic acid was added to 
the kinase reaction following phosphatase removal to inhibit any residual phosphatase. 
Again, the Cdc7 kinase remained inactive (Figure 4A, lane 7). Thus, we conclude that the 
absence of histone HI kinase activity in the phosphatase treated Cdc7 protein is due to 
removal ofphosphate(s) important for kinase activity. 
Cdc28 Protein Can Phosphorylate Cdc7 Protein Directly 
The preceding experiments suggested that Cdc7 protein could be a substrate of the 
Cdc28 kinase. In order to directly test this, the Cdc7 protein had to be purifted so that it 
could be used as a substrate. Cdc7 protein was expressed in E. coli as a fusion protein 
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with the hemagglutinin epitope (see Experimental Procedures for details). Although a 
number of different conditions were tested, the bacterially produced fusion protein, desig-
nated HA-Cdc7 protein, was not active as a kinase, in contrast to that produced in yeast 
(see Figure 4). In addition, Cdc7 protein expressed in E. coli was not phosphorylated (our 
unpublished data). The unphosphorylated Cdc7 protein was therefore ideally useful as a 
substrate to test the effects of phosphorylation by Cdc28 immune complexes. 
Antibodies raised against the N-terminal 11 amino acids of Cdc28 protein (gift of 
M. Tyers and A. B. Futcher, Cold Spring Harbor, NY) were used to prepare Cdc28 
immune complexes. As shown in Figure 5, the Cdc7 fusion protein was phosphorylated 
by the Cdc28 kinase. Two controls were performed to ensure that Cdc28 was responsible 
for the phosphorylation. First, extracts from a wild-type strain and from strain cdc28-13, 
extracts of which contain a thermolabile Cdc28 kinase (Reed et aI., 1985; Wittenberg and 
Reed, 1988), were compared as a source of Cdc28 kinase. The protein kinase reaction was 
carried out at the permissive (25°C) and nonpermissive temperature (38°C) for the cdc28-13 
mutation. Comparison of lanes 1 and 2 in Figure 5 demonstrates that there was less Cdc7 
phosphorylating activity in the immune complexes prepared from cdc28-13 strain at 38°C 
than at 25°C. In contrast, immune complexes from the wild-type strain were more active at 
38°C than at 25°C (lanes 7 and 8). As a second control, the 11 amino acid, Cdc28-derived 
peptide employed as immunogen was used as a competitor in the immunoprecipitation. 
Cdc7 was not phosphorylated when the Cdc28 antibody was preincubated with the Cdc28-
peptide (Figure 5, lanes 5, 6, 11, and 12). Thus, phosphorylation is most likely due to the 
Cdc28 protein. 
Additional proteins were phosphorylated by the Cdc28 immune complexes as 
shown in Figure 5. None of these proteins appeared to be phosphorylated in a Cdc28-
specific way, since the level of phosphorylation was the same at either temperature or the 
kinase activity was thermolabile even in the wild-type strain. However, the -62 kDa band 
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present above the HA-Cdc7 protein could represent a coprecipitating cyelin. We have been 
unable to increase the level of phosphorylation of HA-Cdc7 fusion protein as compared to 
that of other proteins, due to difficulties thus far in obtaining concentrated HA-Cdc7 protein 
in soluble form. The fusion protein precipitates at concentrations higher than 50 ng/Jll 
under reaction conditions tested thus far. 
Similar results have been obtained using p13 beads (gift of W. G. Dunphy; Dunphy 
and Newport 1989) and Cksl antibodies (gift of C. Wittenberg) (data not shown). CKSI 
encodes the S. cerevisiae p13 analog and Cksl antibodies have been shown to coimmuno-
precipitate active Cdc28 kinase along with Cksl protein (Hadwiger et aI., 1989a). Since 
the enzymological specificity of Cdc28 present in Cdc28 kinases prepared with these dif-
ferent reagents has not been characterized, we cannot yet derive any information about 
which of the postulated forms of Cdc28 kinase is active in our experiments. 
Phosphorylation of Cdc7 Protein by Cdc28 Activates the Cdc7 Kinase 
To test whether phosphorylation of Cdc7 by Cdc28 is sufficient to activate the inac-
tive bacterially produced Cdc7 protein, we incubated the Cdc7 protein with Cdc28 immune 
complexes and ATP. The Cdc7 protein was then purified and assayed for ability to phos-
phorylate histone HI. As shown in Figure 6, Cdc7 kinase is active after treatment with 
Cdc28 kinase. Inclusion of the Cdc28 peptide "during preparation of Cdc28 immune com-
plexes competed out the activation and activation did not occur at high temperature when 
cdc28-13 was used as source of the Cdc28 protein. [A report that Cdc7 was active as a 
kinase when prepared in an in vitro translation system could be explained by the presence 
of a Cdc28-like kinase in the translation kit (Bahman et al., 1988).] 
CDC7 Hyperexpression Suppresses the Lethality of cdc28-13 Mutants 
These biochemical experiments suggest that Cdc7 protein is an important physio-
logical substrate of Cdc28. If so, then the two proteins must interact, at least transiently as 
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enzyme and substrate, in vivo. Overproduction of one interacting partner often stabilizes a 
thermolabile form of the other partner, a situation deduced in part from the fact that various 
temperature sensitive mutants can be suppressed by introduction of the gene encoding an 
interacting protein on a high copy number expression vector. The cdc28 alleles have 
proven particularly amenable to this kind of suppression, allowing identification of both G 1 
and G2 cyclins in other studies (Hadwiger et aI., 1989b; Surana et al., 1991). In order to 
see if increasing the intracellular level of Cdc7 protein could suppress the lethality of the 
cdc28 mutation, we introduced a high copy number plasmid carrying CDC7 under control 
of the inducible GAL1,JO promoter into the cdc28-13 strain. We estimate that Cdc7 pro-
tein is overproduced at least to-fold in strains carrying this plasmid, as determined by 
comparison of protein kinase levels in the presence and absence of plasmid (Y oon and 
Campbell, 1991). For the experiment shown in Figure 7, plasmids pSYC758, 
pSYC7-158, and pSEYI8-Gai were transformed into both cdc7-1 and cdc28-13 strains. 
pSYC758 carries wild-type CDC7 under the GAL1,J 0 promoter. pSYC7 -158 contains the 
temperature sensitive cdc7 -1 gene, and pSEY 18-Gal is the vector without a CDC7 allele. 
As shown in Figure 7, only wild-type CDC7 (pSYC758) complements the growth defect 
in cdc7-1 cells at the nonperrnissive temperature (36°C) and that complementation occurs 
even on glucose plates (Figure 7C and 7D, 1). This is most likely due to the leakage of 
glucose repression and the fact that very low levels of Cdc7 protein are required for cell 
cycle progression. The amounts of Cdc7 protein produced in the absence of galactose 
induction are not sufficient for detection by immunoblot (Yoon and Campbell, 1991). We 
then looked at the cdc28 strains. None of the plasmids were able to suppress cdc28-13 
allele at 36°C (7C and 7D, 4-6). However, cdc28-13 cells containing pSYC758 grew and 
formed single colonies at 33°C (7A and 7B, 6). pSYC7-158 also complemented cdc28-13 
mutation at 33°C but only on galactose plates (7A and 7B, 5). Similarly, pSYC7-158 
complemented the cdc7-1 mutation at 33°C after galactose induction (7A and 7B, 2). Since 
the cdc7 -1 sequence encodes a thermolabile protein (see Experimental Procedures), it is 
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reasonable that higher dosage of thermolabile protein is necessary and sufficient to 
suppress the mutations. 
These results show that elevating the intracellular level of Cdc7 protein can rescue 
cells carrying the cdc28-13 mutation. One explanation for this could be that Cdc7 can 
phosphorylate an essential Cdc28 substrate when Cdc7 is overproduced, thus bypassing 
the need for Cdc28. The fact that rescue does not occur at 36°C, suggests that Cdc7 cannot 
bypass Cdc28 and favors the interpretation that Cdc7 protein is interacting at some level 
with Cdc28. As established above, Cdc7 can act as a substrate of Cdc28. In further sup-
port of an interaction between Cdc28 and Cdc7, aside from the enzyme-substrate relation-
ship, we find that Cdc7 protein coprecipitates with Cdc28 in the presence of p 13 beads, as 
evidenced by Cdc? crossreacting material in the p 13 precipitates (Figure 8). The material 
must be Cdc? protein, not only because it has the correct molecular weight (58 kDa) but 
because it is detectable only after Cdc? overproduction (Figure 8, lanes 1 and 2). 
Yeast Replication Protein-A, RP-A as a Substrate of Cdc7 and Cdc28 
Since we have shown that Cdc? kinase is maximally active at the G 1/S boundary 
and since the CDC7 gene is required for entry into S phase, we wished to test the idea that 
activated Cdc? may function in the initiation of mitotic DNA synthesis by phosphorylating 
replication proteins. Several yeast replication proteins were available in purified form in 
this laboratory. Cdc? kinase assays were performed using these proteins as substrates. In 
order to detect Cdc?-specific phosphorylation, we overproduced Cdc? protein in the cdc7-1 
mutant background. Cdc? immune complexes prepared from the mutant strain containing 
either CDC7-overproducing plasmid pSYC758, or control vector pSEY18-Gal were prein-
cubated at 3?OC for 30 min before kinase assay. Under this condition, the endogenous, 
thermolabile Cdc? kinase is inactive and therefore the kinase activity in the immune com-
plexes is most likely due to the Cdc? protein originating from plasmid pSYC758. When 
DNA polymerase a (pol a), DNA polymerase e (pol e), pol e-stimulatory factor I (SFI), 
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ARS-binding factor I (ABFI), or primase were tested, none of them served as a substrate 
of Cdc7 kinase (data not shown). 
Recently, Brill and Stillman (1989) described the yeast analog of the human repli-
cation protein RP-A that is required for SV40 DNA synthesis. Further, they showed that 
the 36 kDa subunit was phosphorylated only during S phase and that phosphorylation 
depended on both Cdc28 and Cdc7 functions in vivo (Din et al., 1990). In cells blocked at 
the cdc7 step, RP-A was not phosphorylated. However, if extracts of cdc7 blocked cells 
were not processed carefully, RP-A did get phosphorylated, suggesting that Cdc7 re-
natured during extract preparation and directly phosphorylated RP-A (Din et al., 1990). To 
study RP-A ph~sphorylation, we purified RP-A from yeast and tested it as a substrate for 
Cdc7 kinase. We first used the monoclonal antibody 12-CA5 to imrnunoprecipitate HA-
Cdc7 fusion protein from wild-type yeast cells containing plasmid pSYCHA7, and found 
that p36 RP-A was strongly labeled by the Cdc7 immune complexes (Figure 9A, lanes 4 
and 5). The HA-Cdc7 fusion protein was also phosphorylated in this reaction (lanes 4 and 
5), consistent with our previous report that native Cdc7 protein contains an autophosphory-
lating activity (Yoon and Campbell, 1991). Phosphorylation of both HA-Cdc7 and p36 
was competed by preincubating the antibody with the hemagglutinin epitope peptide 
(Figure 9A, lanes 2 and 3). Immunoprecipitates prepared from control vector pSEYI8-
Gal containing cells phosphorylated p36, however, at a 4-fold lower level than in HA-Cdc7 
overproducing cells as shown in Figure 9A, lanes 6 and 7. This suggested that Cdc7 
might not be the only protein kinase responsible for phosphorylation of RP-A in cells con-
taining vector alone. Another likely protein kinase may be Cdc28 (see below). We there-
fore overproduced both wild-type Cdc7 protein and thermolabile cdc7 protein in the cdc28-
13 mutant background and carried out kinase assays at the permissive (25°C) and nonper-
missive temperature (38°C) (Figure 9B). When Cdc7 immunoprecipitates were prepared 
from the cdc28-13 strain that overproduced wild-type Cdc7 protein, phosphorylation of 
91 
p36 RP-A was increased at high temperature (Figure 9B, lanes 1 and 2). In contrast to 
this, the clone expressing the thermolabile cdc7 protein contained less kinase activity at 
high temperature (Figure 9B, lanes 3 and 4). Thus, the p36 subunit of RP-A was phos-
phorylated in a Cdc7-dependent manner. (The lower affinity of the polyclonal antibody 
used for the experiment in panel B, perhaps combined with a greater inhibitory effect on 
Cdc7 autophosphorylating activity and the absence of the GALA-expression plasmid from 
this host, did not allow detection of Cdc7 phosphorylation in this experiment) 
Din et al. (1990) showed that RP-A was not phosphorylated in cdc28 mutants. 
Although this could be explained by the fact that Cdc7 phosphorylates RP-A (Figure 9) and 
that Cdc7 is not active in cdc28 mutants (Figure 2), we were interested in seeing whether 
Cdc28 might also phosphorylate p36 RP-A directly. Indeed, as shown in Figure 10, 
Cdc28 immunoprecipitates of yeast specifically phosphorylated the p36 subunit of RP-A. 
The kinase activity in Cdc28 immune complexes was thermolabile in cdc28-13 strain com-
pared to wild-type and competed by Cdc28-peptide (Figure 10). Since the extent of p36 
phosphorylation did not increase in Cdc28 immunoprecipitates prepared from HA-Cdc7 
overproducing cells, when compared to cells with a genomic copy of CDC7, the activity 
was not due to Cdc7 kinase that adventitiously coprecipitated (Figure lOB, lanes 5 and 6). 
Thus, both Cdc28 and Cdc7 phosphorylate the p36 subunit of yeast RP-A in vitro. 
Discussion 
Our studies were initiated in an attempt to define the molecular basis of the role of 
Cdc7 in the initiation of DNA replication inferred from earlier genetic studies. 
Demonstration that CDC7 encodes a protein kinase (Patterson et al., 1986; Hollingsworth 
and Sclafani, 1990; Yoon and Campbell, 1991) led us to test the hypothesis that the essen-
tial function of Cdc7 was to phosphorylate a replication protein at a critical point late in Gl. 
Biochemical experiments showed that Cdc7 kinase activity fluctuates in the cell cycle with a 
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periodicity coinciding with the in vivo function of Cdc7, supporting the prediction that it is 
the kinase activity of Cdc7 that is responsible for its essential role and that it is activation 
rather than abundance that accounts for cell cycle variation. In addition, we showed that 
Cdc7 kinase activity is undetectable in extracts of cells arrested by a cdc28 mutation, that 
phosphorylation of Cdc7 is required for its activity as a protein kinase, that Cdc7 protein is 
hypophosphorylated in cdc28 extracts, and that phosphorylation of Cdc7 protein by Cdc28 
immune complexes is sufficient to activate Cdc7 kinase on a histone HI substrate. 
Overproduction of Cdc7 kinase in vivo could suppress the lethality of a temperature sensi-
tive cdc28 mutation, providing genetic evidence of an in vivo relationship to complement 
the biochemical data demonstrating that the two proteins may interact. The prediction that 
Cdc7 phosphorylates a replication protein was verified by demonstrating that RP-A, whose 
phosphorylation is known to require Cdc7 in vivo (Din et al., 1990), was a substrate of 
Cdc7 kinase and led to the further observation that Cdc28 also phosphorylates RP-A. 
Timing of Cdc' function in the cell cycle 
Early work from the Hartwell laboratory defmed three genes necessary for the ini-
tiation of DNA replication, CDC28, CDC4 and CDC7, as discussed in the Introduction. 
CDC28 functions at START, and after return of cdc28 mutants from the nonpermissive 
temperature the cells can still adopt the alternative pathway of conjugation. Several more 
genes that have this phenotype have been identified, but as yet have not been well studied. 
Three additional genes that affect START, CLNI, CLN2, and CLN3, are apparently 
involved in a positive feedback loop controlling the activation of the CDC28 gene product 
(Cross and Tinkelenberg, 1991; Dirick and Nasmyth, 1991). These genes were identified 
either as suppressors of cdc28 mutations (CLN 1, CLN2) or as dominant gain of function 
mutations (CLN3) (Cross, 1988; Hadwiger et aI., 1989b; Nash et al., 1988; Sudbery et 
al., 1980) and have at least partially redundant functions, in that one CLN gene can com-
pensate for loss of the other, but loss of all three is lethal (Richardson et al., 1989). The 
CLN genes encode proteins that are distantly related to the cyclins that activate the 
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p34/cdc2+/MPF kinase for induction of mitosis in Xenopus, S. pombe and other organ-
isms. By analogy, it has been proposed that CLNI, CLN2 and CLN3 interact with and 
activate the Cdc28 kinase subunit and passage through START (Richardson et al., 1989; 
Wittenberg et aI., 1990; see also Cross, 1988; Nash et al., 1988 and for review Nasmyth, 
1990). The molecular nature of the events set in motion by these START genes, however, 
has been more difficult to define. 
Morphological analysis of single and double mutants and reciprocal shift studies 
suggest CDC7 acts subsequent to CDC28/START (Hereford and Hartwell, 1974). In 
addition to CDC4 and CDC7, three other genes, CDC34, DBF4, and possibly DBF2 also 
function in the post-START/pre-DNA synthesis period (Goebl et aI., 1988; Johnston and 
Thomas, 1982; Chapman and Johnston, 1989; Johnston et aI., 1990). These dependent 
genetic relationships predicted that activation of the Cdc7 protein should be dependent on 
completion of START. In keeping with this, we found that Cdc7 kinase was inactive in 
extracts of cells arrested at START - either by a-factor or by a cdc28 arrest. We then found 
that after release from a block and passage through START the kinase activity increased, 
decreased abrupt! y late in the cell cycle and then rose again in G 1 in the second cell cycle. 
This correlation of appearance of kinase activity and in vivo function is the best evidence to 
date that the kinase activity of Cdc7 is related to its essential and periodic function. 
Genetic studies predicted that Cdc7 activity might be dependent on CDC4, also. 
The results in Figure 2 suggest that, on the contrary, the Cdc7 kinase is already active even 
before CDC4 completes its function. Why does CDC7 appear to depend upon the comple-
tion of CDC4 in vivo? One possibility is that the substrates of Cdc7 kinase may not be 
available during the cdc4 block. According to the results of Hereford and Hartwell (1974), 
cdc4 mutants blocked and released in the presence of the protein synthesis inhibitor cyclo-
heximide do not enter S phase. Further protein synthesis is thus necessary after the CDC4 
step. Proteins newly synthesized after the CDC4 step may include replication proteins that 
require the Cdc7 kinase for post-translational activation. Alternatively, substrates of Cdc7 
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kinase may exist during the cdc4 block, but somehow may be inaccessible to Cdc7 protein 
until after CDC4 has functioned. A third possibility is that Cdc7 kinase, like many other 
kinases, actually consists of two subunits, a catalytic subunit and a regulatory subunit 
whose abundance or modification is dependent on CDC4 function. We feel that it is likely 
that Cdc7 does have a regulatory subunit that enhances activity and is encoded by a second 
yeast gene, since we have recently been able to purify an active Cdc7 kinase from yeast and 
have found that Cdc7 copurifies with an 80 kDa protein, though we have not yet deter-
mined whether this 80 kDa protein represents another substrate or an essential cofactor for 
Cdc7 activity (Loo and Campbell, unpublished). We also observe an 80 kDa protein in 
Cdc7 immunoprecipitates from yeast (see Figure 3, Yoon and Campbell, 1991). 
How is the timing of Cdc7 action controlled? One component of the regulation 
seems to be phosphorylation of Cdc7 protein. Phosphatase treatment of Cdc7 kinase abol-
ishes its histone HI kinase activity (Figure 4). In addition, its phosphorylation state corre-
lates well in the cell cycle with the time when it is active (Figures 2 and 3). It appears likely 
from our studies that Cdc28 kinase provides at least one essential phosphate modification 
(Figures 5 and 6). We also know that Cdc7 is phosphorylated by at least one other kinase, 
in that Cdc7 appears to autophosphorylate (Figure 3 in Yoon and Campbell, 1991; and this 
work Figure 9). 
Is CDC7 a physiological substrate of CDC28? 
Recently, three criteria have been set for establishing a protein as the physiological 
substrate of a particular kinase (Lewin, 1990). First, the amino acid phosphorylated by the 
kinase in vitro should be occupied in vivo at the point in the cell cycle when it is needed. 
Second, a mutation in the kinase should block phosphorylation in vivo. Third, some func-
tion of the protein should be altered by phosphorylation. We have thus far met only the 
second and third criteria in our studies of the Cdc28/Cdc7 interaction, namely that Cdc7 is 
not phosphorylated in cdc28 mutants and it is not active when it is not phosphorylated. 
Given the nature of cell cycle mutants, one could still argue that the effect of the cdc28 , 
95 
mutation is indirect and that another intermediate kinase is required. While this is certainly 
possible, it seems unlikely. For one thing, though many other kinases have been identified 
in yeast, none has been shown to be essential for the CDC28-CDC4-CDC7 pathway as yet. 
A more convincing argument is our demonstration that phosphorylation of Cdc7 by Cdc28 
is sufficient to activate Cdc7 kinase. Thus, the kinase active in vivo must have the same 
specificity as Cdc28. A third argument is that, as shown in Figure 7, CDC7 expressed 
from an inducible GAL promoter on a high copy number plasmid rescues the inviability of 
cdc28-13 cells. Why wasn't CDC7 previously identified as one of the high copy plasmid 
suppressors of cdc28 mutations? Originally, such suppressors were isolated based upon 
their ability to rescue the growth defect of cdc28 mutations at 36°C. In addition, there may 
be allele specificity. Among the dosage-dependent suppressors of cdc28 mutations, both 
CKS1 and CLN genes were isolated using a cdc28-4 allele (Hadwiger et ai., 1989a; 
1989b). The ability to suppress the lethality of cdc28-1N allele but not that of a cdc28-4 
allele led to the discovery of CLB genes (Surana et al., 1991). In the study described here, 
we used a cdc28-13 allele. Finally, in our experiments, CDC7 did not suppress simply by 
virtue of being present on a high copy plasmid but required induction from a GAL pro-
moter, which led to higher intracellular concentrations of CDC7 than can be expected from 
simple increase in gene dosage of CDC7 under its own, perhaps stringently regulated pro-
moter. 
It is essential that we now fulfill the first criteria for correspondence of in vitro and 
in vivo substrates mentioned above. The consensus motif for a cdc2+/Cdc28 phosphoryla-
tion site has been reported to be S{f-P-X-Z (where X is a polar amino acid, and Z is 
generally a basic amino acid) (for reviews, see Lewin, 1990; Moreno and Nurse, 1990 and 
Pines and Hunter, 1990). The primary amino acid sequence of CDC7 contains one such 
motif, TSS83PQR, near the N-terminus, adjacent to the A TP binding site. Mutation of S83 
to A 83 results in failure to complement a cdc7 -lor a cdc7 Ll mutant (Loo, Y oon and 
Campbell, unpublished), consistent with but not proving that S83 is the site of a crucial 
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phosphorylation. In some cases, even the simple sequence srr-p is recognized by cdc2+ 
kinases (see references in Roach, 1991). Cdc7 contains three SP or TP sites which lie in 
the C terminal half of Cdc7. Mutations of the respective serines and threonines in these 
positions have no effect on in vivo function (Loo, Y oon and Campbell, unpublished). 
Which form of Cdc28 might be involved in the Cdc7 activation? Either by using 
the cdc28-1N allele or by modifying the restrictive conditions and using cdc28-4 and 
cdc28-13, alleles that were previously used to define the CDC28-CDC4-CDC7 pathway, it 
was shown that CDC28 has an execution point in G2 as well as Gl(Piggott et aI., 1982; 
Reed and Wittenberg, 1990; Surana et al., 1991). Results presented in this paper suggest 
that CDC28 may be required for at least two more post-START events closely linked to exit 
from G 1 - to phosphorylate Cdc7 and to phosphorylate RP-A. CDC28, CDC7 and the 
initiation of DNA synthesis do not appear to be interdependent based on previous assays of 
cell cycle function. Previous definitions of START were based on morphological land-
marks - bud size, spindle development, nuclear migration. The addition of biochemical 
landmarks - CLN transcription, Cdc7 phosphorylation and RP-A phosphorylation, 
expand the range of assays for CDC28 function and may allow a finer dissection and 
enzymological characterization of the multiple activities of Cdc28 and its complexes. For 
instance, it may be possible to use these phenomena as assays to differentiate the functions 
of the various cyclins. The various phosphorylation states of Cdc28, which do not appear 
to change with passage through START (Hadwiger and Reed, 1988) may be different for 
Cdc7 and RP-A phosphorylation. Since the relationship of the CDC7 step and START is 
not clear, it will be of particular interest to see if phosphorylation of Cdc28 is required for 
the kinase to phosphorylate the Cdc7 protein. In Schizosaccharomyces pombe, it has been 
shown that T167 phosphorylation of cdc2+ is involved in the association of cdc2+ with 
cdcl3+ (Gould et al., 1991). In sum, while the precise relationship of the post-START 
functions to START is not yet clear, there is accumulating evidence that the transitions in 
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the cell cycle are monitored by Cdc28, or one of its homologs, at more discrete stages than 
just the two previously defined commitment points-START and G2/M. 
Exit from Gl and Entry into S, What is the Gl/S Transition? 
Presumably the signals integrated at START that commit the cell to growth and 
replication must eventually be communicated to the replication apparatus itself. In the case 
of SV40 DNA replication, cdc2+ kinase has been shown to phosphorylate T124 of 
T antigen, which is essential for T antigen's function in DNA replication (McVey et al., 
1989). D'Urso et al. (1990) have also presented evidence that some component of the 
replication apparatus is modified by a cyclin A dependent, cdc2+ kinase in human cells late 
in G 1. The initiator protein for chromosomal DNA replication has not been isolated yet and 
so the host protein analogous to T antigen is not available to test as a substrate of the G 1 
kinases. Previous results by Din et al. (1990), however, showed that the p36 subunits of 
both human and yeast RP-A were phosphorylated at a specific point in the cell cycle, late in 
G 1 or early in S phase. Not only did this coincide with the timing of Cdc7 function, but 
also the p36 subunit of yeast RP-A was not phosphorylated in cdc7-ts cells arrested at the 
nonperrnissive temperature. Interestingly, it was also unphosphorylated in cdc28-ts cells. 
In the process of searching for substrates of Cdc7 kinase, we identified RP-A as an in vitro 
substrate of both Cdc7 and Cdc28 (Figures 9 and 10). We have thus added biochemical 
evidence to the implied result of the previous work by Din et al. (1990) that replication 
protein RP-A is a substrate of Cdc28 and Cdc7. 
This biochemistry raises several obvious questions. Is phosphorylation of RP-A 
by either or both kinases essential in vivo? Do they modify the same or different amino 
acids? Is RP-A the only substrate of Cdc7 and Cdc28 that participates in chromosomal 
DNA synthesis? At present we do not have sufficient information to decide if either kinase 
is the physiological kinase and whether phosphorylation of RP-A is either necessary or 
sufficient to trigger DNA replication. Perhaps both kinases must act on this substrate for 
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yeast cells to enter S phase. Previous phosphory lations are often necessary for secondary 
ones to occur (Roach et al., 1991). It is very important to emphasize that the phosphory-
lated doublet of p36 RP-A reported by Din et al. (1990) does not appear until after Cdc7 
has functioned. It does not appear directly after the CDC28 or even after the CDC4 step, 
where the Cdc7 kinase is active, at least in vitro. It is also noteworthy that both Cdc7 and 
both the phosphorylated and unphosphorylated forms of RP-A are localized in the yeast 
nuclei (Yoon and Campbell, 1991; our unpublished data). CDC28 could be required only 
to activate Cdc7, or alternatively, since Cdc28 directly phosphorylates RP-A in vitro, 
Cdc28 could use RP-A as a direct substrate in vivo as well. The idea that Cdc28 may act 
both as a master regulator of START and a direct activator has been raised previously, and 
our results may constitute evidence for such a dual role in the Gl phase of the yeast cell 
cycle. Experiments are under way to map the sites of phosphorylation by Cdc28 and Cdc7 
in p36. 
In conclusion, our studies provide biochemical evidence supporting, as well as 
refining, the existing S. cerevisiae genetic cell cycle map. Future studies will be aimed at 
obtaining additional in vivo data. 
Experimental Procedures 
Strains, Media and Plasmids 
The genotypes and sources of the yeast strains used were SEY6210, a his3 leu2 
lys2 suc2 trpl ural (S. D. Emr, California Institute of Technology); YC7379, a adel his7 
/ys2 tyrl ura3 cdc7-l (Yoon and Campbell, 1991); CU4-1, a adel ura3 cdc4-l 
(A. Y. long, University of Southern California); USC6-5, a leu2 ura3 cdc6-l 
(A. Y. Jong, University of Southern California); YC488m, a hisl leu2 poll-l 7 trpl ural 
canl (M. Budd, California Institute of Technology); YC28, a adel his3 ural cdc28-13 
(this work); GI906c, a barl-lleul rmel trp5 ural can] cir+ (A. Y. Jong, University of 
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Southern California). Cells were routinely grown in YPD medium (1 % yeast extract, 2% 
Bacto peptone, 2% glucose) or synthetic minimal medium supplemented with amino acids 
and adenine but lacking uracil. Either 2% glucose or 2% raffinose plus 2% galactose were 
used as the carbon source. For in vivo 32pj labeling, cells were grown in LPSM medium 
(Reneke et al., 1988). E. coli cells were grown in LB medium containing ampicillin (50 
~g/ml). In order to overexpress wild-type CDC7 , thermolabile cdc7-1, and the 
CDC7-hemagglutinin fusion gene in yeast, we used a high copy number, 2 ~m containing 
vector pSEYI8-Gal (S. D. Emr). pSEYI8-Gal also contains the URA3 gene and the 
inducible GALl,lO promoter. pSYC758 carries wild-type CDC7 under the GALLO 
promoter .ofpSEYI8-Gal (Yoon and Campbell, 1991). pSYC7-158, carries a temperature 
sensitive cdc7-l gene under the GALl,10 promoter, and was constructed for this work as 
explained in detail below. pSYCHA7 carries the CDC7-hemagglutinin epitope fusion gene 
under the control of the GALl,10 promoter (see below for details). The T7 promoter 
containing vector, pT7 -7 (Tabor and Richardson, 1985), was used to express the 
Cdc7 -hemagglutinin epitope fusion protein in E. coli. 
Buffers and Inhibitors 
The buffers and inhibitors used were as follows: IP buffer (imrnunoprecipitation 
buffer), 50 roM Tris-HCI at pH 7.5, 150 mM NaCI, 0.5% Tween 20, 0.2 roM EDTA, and 
protease inhibitors; K buffer (kinase buffer), 25 mM Tris-HCI at pH 7.5,5 mM NaP, 15 
roM MgCh, 5 roM EGTA, and protease inhibitors; L buffer (lysis buffer), 100 roM Hepes 
at pH 7.9,1% sodium deoxycholate, 1% Triton X-100, O. I% SDS, 0.2 roM EDTA, 0.2 
roM EGTA, 2.5 roM dithiothreitol, protease inhibitors, and phosphatase inhibitors; AP 
buffer (acid phosphatase buffer), 10 roM Pipes at pH 6.0 and protease inhibitors; CIP 
buffer (calf intestinal alkaline phosphatase buffer), 50 roM Tris-HCI at pH 8.0, 25 roM 
NaC!, 5 roM MgCI2, and protease inhibitors; protease inhibitors, 1 mM phenylmethyl-
sulfonyl fluoride, 1 roM benzamidine, 10 ~g/ml pepstatin A, 10 ~g/ml leupeptin and 10 
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).1g/rnl soybean trypsin inhibitor; phosphatase inhibitors, 10 mM sodium azide, 10 mM 
sodium fluoride, 10 mM sodium molybdate, 10 mM sodium pyrophosphate, 10 mM 
potassium phosphate, I mM EDT A, and I mM EGT A. Okadaic acid was used at 5 J.1M. 
Antisera 
The production of polyclonal Cdc7 antibody is described in Yoon and Campbell 
(1991). To purify the Cdc7 antibody, an affinity column was made by linking 5 mg of 
bacterially produced Cdc7 protein to 1 g of CNBr-activated Sepharose as recommended by 
Pharmacia. Using this Cdc7 affinity column, the antibody was purified according to the 
method detailed in Harlow and Lane (1988). The monoclonal antibody 12-CA5, a sub-
clone of H26DD8 (mouse IgG 2b) was raised against the influenza hemagglutinin peptide 
(HA; YPYDVPDY A) as previously described by Field et al. (1988). The hybridoma was 
kindly provided by D. J. Anderson (California Institute of Technology), and was cultured 
in the Caltech Monoclonal Antibody Facility. The anti-HA peptide antibody was purified 
from ascites fluid using a protein A-Sepharose column according to manufacturer's 
instructions (Sigma). Antibodies to the 11 N-terminal amino acids of Cdc28 as well as the 
N-terminal peptide immunogen were the gift of M. Tyers and A. B. Futcher, Cold Spring 
Harbor, NY. p13 beads were the gift of W. G. Dunphy, California Institute of 
Technology, Pasadena, CA. 
Immunoprecipitations and Protein Kinase Assays 
Either whole cell or nuclear extracts were used to prepare immune complexes. The 
amounts of extracts and antisera used are indicated specifically in each Figure legend. 
Immune complexes were precipitated with 2D).11 of protein A-Sepharose beads (100 mg/rnl; 
Sigma), washed four times in IP buffer, twice in K buffer, and resuspended in 25 ).11 of K 
buffer. After 5 min preincubation at 25°C or 38°C, D.l mM ATP, 10 ).1Ci [y..32p] ATP 
(3000 Ci/mmol, Amersham PB 10168) and substrate were added to a final vol of 36 ).11. 
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Incubation was continued at the same temperature for 20 min and reaction products were 
analyzed on 10% SDS-polyacrylamide gels. 
Purification of "A-Cdc7 Fusion Protein from E. coli 
Since we had previously shown that the N-terminal 20 amino acids were dispens-
able for CDC7 function in vivo (Yoon and Campbell, 1991), we chose to add the 
hemagglutinin epitope (HA) to the N-terminus of the Cdc7 protein. Plasmid pTIIA-CDC7 
encoding the hemagglutinin epitope-Cdc7 fusion protein, called HA-Cdc7 in the text, was 
constructed from the plasmid pTI-CDC7. pTI-CDC7 carries the complete CDC7 gene 
cloned into the TI promoter based vector pTI-7, and has a unique NdeI site which marks 
the initiation codon for CDC7. To construct pTIIA-CDC7, the synthetic oligonucleotide 
5'-TATGTACCCA TACGATGTTCCAGATTACGCT AGCTTGGGTGGTCC-3' 
encoding the HA epitope, YPYDVPDY A, and the linker sequence, SLGGP, was inserted 
into the NdeI site of pTI -CDC7. The linker GGP is used to connect the HA peptide to the 
CDC7 gene because it is expected to cause the HA peptide to protrude from the rest of the 
protein. Then, the junction sites of recombinant clones were sequenced to confmn the 
cloning procedures yielded an in-frame fusion gene. 
For expression of the HA-Cdc7 fusion protein in E. coli, pTIIA-CDC7 was trans-
formed into the bacterial strain BL21 (DE3) (Sfudier and Moffat, 1986). This strain carries 
the TI RNA polymerase gene under the control of the lacUV5 promoter. Cells carrying 
pTHA-CDC7 were grown in 500 ml of LB medium supplemented with ampicillin (50 
Jl.g/ml) to an OD600 of 0.5. The polymerase, and hence the. HA-CDC7 fusion gene, were 
induced by the addition of isopropyl ~-D-thiogalactoside (IPTG) to a final concentration of 
0.5 mM, and the culture was allowed to grow for another 3 hrs. Cells were harvested, 
resuspended in 20 ml of ice-cold 10 mM Tris-HCl at pH 7.4, 100 mM NaCI, 1 mM 
MgCI2, 10 l1g/mllysozyme, protease inhibitors, and disrupted by sonication with four 30 
sec pulses. The inclusion bodies containing the insoluble HA-Cdc7 fusion protein were 
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isolated by centrifuging the bacterial extracts at 10,000 rpm for 10 min at 4°C in a Sorvall 
SS34 rotor. The pellet was resuspended in 200 mM Tris-HCI at pH 8.2, 500 mM NaCI, 
0.1 % Triton X-l00, 1 mM dithiothreitol, sonicated once for 30 sec, and centrifuged again 
at 10,000 rpm for 10 min. The final pellet was dissolved in 50 ml of buffer A (25 mM 
Tris-HCI at pH 8.0, 1 mM dithiothreitol, and 6 M urea). 
To purify HA-Cdc7 fusion protein, protein extracts were loaded onto 20 ml of 
DEAE-Cellulose (Whatman) column that had been equilibrated with buffer A containing 25 
mM NaCI. After washing the column with two column vol of buffer A with 50 mM NaCI, 
proteins were eluted by a linear gradient of 50-500 mM NaCl in buffer A. The HA-Cdc7 
fusion protein was eluted at about 250 mM NaCl, as determined by protein blotting of the 
fractions with Cdc7 antibody. The fractions containing the fusion protein were pooled, 
diluted to a protein concentration of about 50 ngl~1 with buffer B (200 mM Tris-HCI at pH 
8.0, 500 mM NaCl, and 1 mM dithiothreitol) containing 6 M urea, and dialyzed against 
buffer B with 4 M urea for more than 8 hrs. The concentration of urea in the dialysis 
buffer was gradually reduced from 4 M to 2 M, 1 M, and finally 0 M. The length of dialy-
sis in each urea concentration was for more than 8 hrs each. The fusion protein was judged 
to be more than 90% pure by Coomassie blue staining following SDS-polyacrylarnide gel 
electrophoresis. 
Expression of HA-CDC7 Fusion Gene in Yeast 
To produce HA-Cdc7 fusion protein in yeast, pTHA-CDC7 was first digested with 
NdeI and SphI. The 1.8 kb DNA containing the HA-CDC7 fusion gene was then treated 
with T4 DNA polymerase, EcoRI linkers were attached and the fragment was ligated into 
the EcoRI site of the yeast expression vector, pSEY18-Gal. The resulting plasmid, 
pSYCHA 7, carries HA-CDC7 gene under the control of the inducible GALl ,10 promoter 
and is capable of efficiently suppressing the temperature sensitive phenotype of a cdc7-l 
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allele at the nonpennissive temperature, 36°C. Thus the epitope does not seem to interfere 
with Cdc? function in vivo when fused to the Cdc? protein. 
Cloning of the cdc7-1 allele and Overproduction of Thermolabile cdc?-! 
Protein in Yeast 
The mutation in cdc7-] has been mapped between the Sacl and SphI sites 
(Patterson et al., 1986). The polymerase chain reaction was performed in a Perkin Elmer 
Cetus DNA Thermal Cycler using -150 ng of yeast genomic DNA isolated from strain 
cdc7-] and 51!g each of the oligonucleotide primers (5' primer, 5'-TAT AAT GAG CTC 
AAC CTG CTG TAC ATA ATG ACO-3', where the Sacl site is underlined; 3' primer, 5'-
CTT AAG CGC ATG CCA CCA A TT ATG CTA AAC COT-3' in which the SphI site is 
underlined). The plasmid containing the temperature sensitive allele, pSYC?-158, was 
constructed by ligation of the 1,393 basepair Sacl/SphI PCR fragment of the cdc7 -1 allele 
into the Sacl and SphI sites of plasmid pSYC?58, which expresses wild-type Cdc? protein 
from the GALlO promoter (Yoon and Campbell, 1991). This creates an in-frame fusion of 
the 3'-1,393 basepairs of the cdc7-] allele to the 5'-282 basepairs of the CDC7 gene. 
Clones were transformed into a heterozygous diploid, CDC7/cdc7::Tn3, carrying a dis-
rupted cdc7 allele, which was constructed for this test. After sporulation, the spores con-
taining plasmids and disruptions grew but were temperature sensitive. Thus, the clone 
complements a gene disruption and gives a temperature sensitive phenotype. As expected, 
the clone does not complement cdc7-] strains at 36°C. Protein extracts were prepared from 
a cdc7-1 strain containing either pSYC758 (wild-type CDC7) or pSYC?-158 (ts cdc7-1). 
Immunoblot analysis of these extracts confirmed that the cdc?-l protein was overproduced 
at the permissive temperature (data not shown). 
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Figure 1. The Activity of Cdc7 Kinase Accumulates Periodically During 
the Cell Cycle. 
Strain 01906c bar] carrying the CDC7-overproducing plasmid, pSYC758, was grown at 
30"C in 2 liters of 2% raffinose synthetic complete (SC) medium (minus uracil). At OD595 
= 0.5, cells were treated with 2% galactose and synchronized in 01 with 300 ng/ml n-
factor for 7 hr. Cells were washed twice with fresh SC medium (minus uracil) containing 
both 2% raffinose and 2% galactose, and resuspended in 1.5 liters of the same medium to 
release cells from mating pheromone arrest. Samples (50 ml) were taken at 20 min inter-
vals for 400 min. Whole yeast lysates were prepared from each sample by vortexing in the 
presence of glass beads and clarified by centrifugation. The supernatants, which contain 
no detectable Cdc7 protein, were discarded and the pellets were resuspended in L buffer, 
incubated for 30 min on ice, and centrifuged twice to remove insoluble materials. Protein 
extracts were analyzed by immunoblotting for Cdc7 quantitation and by histone HI kinase 
assay for Cdc7 activity. Protein (40 Ilg each) blots were stained with Cdc7 antibody 
(1 :250 dilution) and the Bio-Rad ImmunBlot assay kit (goat anti-rabbit IgG alkaline phos-
phatase conjugate). For histone HI kinase assay, Cdc7 immune complexes were prepared 
as described in Experimental Procedures using 120 Ilg of protein and 20 J.1l of Cdc7 anti-
body. The reaction was carried out at 38°.C for 20 min with 5 Ilg of histone HI 
(Boehringer Mannheim) and the products were visualized by autoradiography after separa-
tion on 10% SDS-polyacrylamide gels. For parameters of cell cycle synchrony, samples 
taken at each time point were fixed with 3.7% formaldehyde and scored for cell mor-
phology by phase-contrast microscopy. Symbols: Triangle, unbudded cells; Square, cells 
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Figure 2. Cdc7 Kinase Is Not Active in Cells Arrested at START. 
cdc strains (cdc28-13, cdc4-1, and poll-l 7) were grown at 25°C and a barl strain at 30°C 
in YPD media. At OD595 = 0.7, cdc strains were shifted to 38°C and held there until 
approximately 90% of the celis were arrested with the appropriate terminal phenotype 
(lanes 6-8). bar 1 cells were treated with a-factor (oF; 300 ng/ml final concentration), 
hydroxyurea (lIU; 0.2 M final concentration), or nocodawle (NC; 20 ~g/ml final concen-
tration) for 4 hr at 30°C (lanes 2-4). Nuclear protein extracts (500 ~g) prepared from these 
strains were immunoprecipitated with affinity purified Cdc7 antibody (20 ~l) and assayed 
for histone HI kinase activity. The reaction was carried out at 38°C for 20 min with 5 ~g 
of histone HI. As a control, histone HI was incubated in the absence of Cdc7 immune 
. complexes (lane 1). For the cdc28-13 strain, nuclear extracts were also prepared from cells 
grown constantly at 25°C and tested for the histone HI kinase activity at 25°C for 20 min 
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Figure 3. Labeling of Cdc7 Protein with 32Pj in Cells Arrested at Different 
Points in the Cell Cycle. 
Yeast strains (cdc28-13, cdc4-1, cdc6-I,poll-17, and wild-type) carrying the CDC7-over-
producing plasmid, pSYC758, were grown at 25°C in 20 ml of LPSM medium. Both 2% 
raffinose and 2% galactose were used as a carbon source. At OD595 = 0.5, the temperature 
was shifted to 38°C for 3 hr. Cells were then labeled with 0.7-1.0 mCi of 32Pj for 2 hr at 
38°C (lanes 2-6). For the cdc28-13 strain, cells grown constantly at 25°C were also labeled 
with 32pj for 2 hr at 25°C (lane 1). Whole yeast lysates were prepared as described in the 
legend to Figure 1. Proteins were immunoprecipitated with affinity purified Cdc7 antibody 
(20 ~l) and analyzed by electrophoresis in a 10% SDS-polyacrylamide gel. The gel was 
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Figure 4. In Vitro Inactivation of Cdc7 Kinase with Phosphatase. 
(A) Three separate Cdc7 immune complexes were prepared from nuclear extracts (500 ~g 
each) of Cdc7-overproducing cells using affinity purified Cdc7 antibody (20 ~ each; lanes 
1-3). After washing four times in IP buffer, two of them were washed twice in CIP buffer 
and incubated for 15 min at 37°C in the presence (+) or absence (-) of 3 U of CIP (lanes I 
and 2). The third immune complex was treated with 3 U of AP after washing twice in AP 
buffer (lane 3). Each immune complex was then washed three times in IP buffer and twice 
in K buffer, and assayed for histone HI kinase activity (15 min at 37°C) (lanes 1-3). 
Whole celllysates were prepared from cells overproducing the hemagglutinin-Cdc7 
fusion protein (HA-Cdc7). Extracts were made from cells (1 liter) harvested at OD595=2 
by extensive manual grinding under liquid nitrogen as described by Schultz et al. (1991). 
The powder of broken cells were resuspended in L buffer and centrifuged at 20,000 rpm 
for 30 min. The supernatant was frozen in aliquots at -70°C until needed. The monoclonal 
antibody I2-CA5 (20 ~l each) was used to immunoprecipitate HA-Cdc7 fusion protein 
from these extracts (400 ~g each; lanes 4-7). Immune complexes were washed as above 
and incubated with (+) or without (-) 3 U of AP before assay for HI kinase activity (lanes 
4 and 5). In lane 6, immune complexes of AP-treated (1/2) and untreated (1/2) samples 
were combined and tested for kinase activity. Lane 7 contained immune complexes treated 
in the same way as those in lane 5 except okadaic acid (5 ~M) was added in the kinase 
reaction. Reaction products were analyzed on an SDS-polyacrylamide gel, stained with 
Coomassie blue, dried, and autoradiographed. 
(B) Three separate Cdc7 immune complexes were prepared from Cdc7-overproducing 
cells using affinity purified Cdc7 antibody. After washing four times in IP buffer, two 
samples were washed twice in CIP buffer and incubated for 15 min at 37°C in the presence 
(+) or absence (-) of 3U of CIP (lanes 1 and 2). The third immune complex was treated 
with 3U of AP after washing twice in AP buffer (lane 3). Each immune complex was then 
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Figure 5. Phosphorylation of Cdc7 Protein by Cdc28 Immune Complexes. 
Whole yeast lysates were prepared from a cdc28-13 strain and a wild-type strain as de-
scribed in the legend to Figure 4. The Cdc28 kinase was then immunoprecipitated from 
these extracts (100 Jlg each) with excess antibody (2 J.1l each) raised against the N-terminal 
11 amino acids of Cdc28 protein (lanes 1-4 and 7-10), or with the same antibody preincu-
bated with 30 Jlg of the N-terminal peptide (lanes 5, 6, 11, and 12). Cdc28 immune com-
plexes were prepared from cdc28-13 strain in lanes 1-6 and from wild-type strain in lanes 
7-12. Kinase reactions were carried out at 25°C (lanes 1, 3,5,7,9, and 11) or 38°C (lanes 
2, 4, 6, 8, 10, and 12) using 500 ng of HA-Cdc7 fusion protein as substrate. The fusion 
protein was purified out of E. coli cells as explained in Experimental Procedures. In lanes 
3, 4, 9, and 10, Cdc28 immune complexes were incubated in the absence of the fusion 
protein. Products were analyzed by electrophoresis on a 10% SDS-polyacrylamide gel, 
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Figure 6. Cdc28 Kinase Activates Cdc7 Kinase In Vitro. 
Cdc28 immune complexes were prepared from a cdc28-13 strain as described in the legend 
to Figure 5. In lane 3, the Cdc28 antibody was preincubated with 30 I1g of the Cdc28 
peptide. After 5 min at 25°C (lanes 1-3) or 38°C (lane 4), either 20 111 of HA-Cdc7 fusion 
protein in buffer B (1 I1g each; lanes 2-4) or 20 111 of buffer B alone (lane I) were added 
together with 1 mM A TP. The fusion protein purified out of E. coli cells were resuspended 
in buffer B at a concentration of about 50 ngil11 (see Experimental Procedures for details). 
Incubation continued at the same temperature for 10 min and reaction mixtures were cen-
trifuged for 1 min to remove Cdc28 immunoprecipitates. The supernatants that contained 
either HA-Cdc7 protein or buffer alone were preincubated at 38°C for 5 min to inactivate 
any residual Cdc28-dependent kinase. Then, kinase reactions were carried out at 38°C for 
10 min using 0.1 mM ATP, 10 I1Ci [y.32p] ATP, and 511g of histone HI. Reaction prod-
ucts were analyzed by electrophoresis on a 10% SDS-polyacrylamide gel. 
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Figure 7. The Temperature·Sensitive Phenotype of the cdc28-13 Mutation 
Can Be Complemented by CDC7 Overexpression. 
Yeast strains cdc7-1 (1-3) and cdc28-13 (4-6) were transformed with plasmid pSYC758 (I 
and 6), pSYC7-158 (2 and 5), or pSEYI8-Gal (3 and 4). Transformants were isolated on 
uracil-deficient, glucose plates at the room temperature (25°C). To determine the ability of 
plasmids to suppress the mutations, single colonies were streaked out on both glucose and 
galactose plates (minus uracil) and incubated at either 33°C or 36°C. 
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Figure 8. Cdc7 Protein Is Precipitated by p13 Beads. 
Protein extracts (4 mg in lane 1; 2 mg each in lanes 2 and 3) prepared from a wild-type 
yeast strain carrying either CDC7-containing pSYC758 (lanes 1 and 2) or vector pSEYI8-
Gal (lane 3) were precipitated with p13 beads (60 III in lane 1; 30 III each in lanes 2 and 3). 
After washing 5 times with K buffer (200 III for each time). proteins bound to the p13 
beads were subjected to immunoblot analysis using polyclonal Cdc7 antibody as probe. 
Supernatant contained 90% of the Cdc7 protein (not shown). 
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Figure 9. Cdc7 Protein Phosphorylates p36 RP-A. 
(A) Yeast extracts (200 ~g) prepared from cells containing either pSYCHA 7 (HA-Cdc7 
fusion protein overproducing plasmid; lanes 2-S) or control vector pSEY18-Gal (lanes 6 
and 7) were immunoprecipitated using the monoclonal antibody 12-CAS (20 ~I). In lanes 
2 and 3, the antibody was preincubated with the hemagglutinin peptide (SO ~g). Kinase 
assays were performed at either 2SoC (lanes 2, 4, and 6) or 38°C (lanes 3, S, and 7) with 2 
~g of yeast RP-A (-700 ng p36) as substrate. In lane 1, RP-A was incubated in the kinase 
assay in the absence ofimmunoprecipitates at 38°C. Yeast RP-A was purified according to 
the published protocol (Brill and Stillman, 1988). 
(B) The polyc1onal Cdc7 antibody (20 ~I each) was used to prepare immune complexes 
from cdc28-13 mutant cells (200 ~g proteins), which overproduced either wild-type Cdc7 
protein (lanes 1 and 2) or thermolabile cdc7 protein (lanes 3 and 4). Cells were grown at 
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Figure 10. Phosphorylation of RP-A by Cdc28 Kinase. 
(A) The Cdc28 kinase was irnmunoprecipitated from cdc28-13 extracts (200 Ilg each) with 
the polyc1onal antibody raised against the N-terminal peptide (4 III each; lanes 3 and 4), or 
with the same antibody preincubated with the epitope peptide (50 Ilg; lanes 1 and 2). 
Kinase reactions were done as described in the legend to Figure 9. 
(B) The ability to phosphorylate yeast RP-A was measured as in (A) except that Cdc28 
immune complexes were prepared from Wild-type yeast cells carrying either pSEY18-Gal 
(lanes 1-4) or pSYCHA 7 (lanes 5 and 6). 
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Expression of Double-Stranded-RNA-Specific RNase III of 
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The gene for the double-stranded RNA (dsRNA)-spl..'Cific RNase III of Escherichia coli was exprcssl..'11 in 
Saccharomyces cerevisiae to examine the etTects of this RNase activity on the yeast. Induction of the RNase III 
gene was found to cause abnormal cell morphology and cell death. Whereas double-stranded killer RNA is 
degraded by RNase III in vitro. killer RNA. rRNA. and some mRNAs were found to be stable in vivo after 
induction of RNase III. Vadants selected Cor resistance to RNase III induction were isolated at a frequency of 
4 x 1O-s to 5 x 10-5• Ten percent of these reSistant strains had concomitantly lost the capacity to produce 
killer toxin and M dsRNA while retaining L dsRNA. The genetic alteration leading to RNase resistance was 
localized within the RNase Ill-coding region but not in the yeast chromosome. These results indicate that S. 
cerevisiae contains some essential RNA which is susceptible to E. coli RNase III. 
It is known that double~stranded RNA (dsRNA) plays 
various important roles in procaryotes. as well as in eucary-
otes. For example, formation of dsRNA between mRNA and 
targeted antisense RNA blocks expression of a specific gene 
(for a review, see reference 8); fonnation of dsRNA is an 
important step during virus infection (e.g .• see reference 24), 
RNA maturation (19). and interferon induction (14). Esche-
richia coli is known to contain a dsRNA-specific RNase 
called RNase III. This enzyme introduces specific cleavages 
in a number of RNA (rRNA and mRNA) precursors in E. 
coli as part of the RNA maturation process (6). In contrast to 
various single-stranded RNases, RNase III nonspecifically 
degrades dsRNA (21). RNase III is able to cleave RNA-
RN A duplexes greater than 20 base pairs long, producing 
fragments an average size of 15 base pairs long (20). The E. 
coli RNase III gene has been cloned (25), and its DNA 
sequence has been detennined (16, 18). It is intriguing to 
examine whether RNase III expression in eucaryotes results 
in specific effects on cell growth, gene regulation. cell 
physiology, cell morphology. or cell viability. 
In this study. we examined expression of the E. coli 
RNase III gene in Saccharomyces arevisiae and its effects 
on cell growth and cell RNA. We found that induction of 
expression of the RNase III gene resulted in abnormal cell 
morphology and cell death. We were able to isolate cells that 
became resistant to RNase [II induction at a frequency of 4 
x 10-!' to 5 x 10- s. Among those resistant strains. approx-
imately 10% were found to be cured of the killer factor M 
dsRNA. Analysis of the resistant strains revealed that the 
mutation was localized within the RNase III-coding region. 
These results indicate that yeast cells possess essential 
RNAs containing a double-stranded structure(s). Degrada-
tion of this double-stranded structure is considered to result 
in cell death. 
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MATERIALS AND METHODS 
Strains. plasmids, and growth conditions. The strain 
DMMl~15A (leu2 ura3 ade2 hisS) and the plasmid YEp51 (2) 
were kindly provided by J. Broach of Princeton University, 
New Jersey. Strain S228 and the assay for yeast killer toxin 
were described by Sherman et al. (22). The growth medium 
(SD) used in all the experiments contained 0.67% (wt/vol) 
yeast nitrogen base without amino acids (Difco Laborato-
ries. Detroit. Mich.) and 2% (wtlvol) glucose. galactose, or 
raffinose and was supplemented with the appropriate amino 
acids. Cultures for growth experiments. RNA preparations, 
and labeling experiments were pregrown to the stationary 
phase (12 to 24 h) in SD-glucose medium at 30"<:. These 
cultures were then inoculated into fresh SD medium supple-
me nted with the appropriate carbon source. In growth 
experiments. culture turbidity was monitored by measuring 
optical density at 660 nm, and cell viability was monitored by 
plating appropriate dilutions on SD-glucose plates (2% agar). 
Lithium acetate DNA-mediated transformation was used for 
S. cerevisiae. (11). E. coli S8221 and standard cloning 
techniques have been previously deseribed (15). Variant 
strains resistant to RNase III induction were isolated by 
plating culture of DMMl-15A::pPY2 on SD-galactose plates. 
Cell labeling and immunopredpitatioa. S. cerel'isiae 
DMMl-15A cells containing the appropriate plasmid were 
grown to 2 x 101 cells per mi. harvested. and resuspended in 
the same SD medium lacking methionine. After the cells 
were grown for 30 min at 30"C. 100 ~ of (l!'S]methionine 
was added to a 5~ml culture and the cells were incubated for 
1 to 2 h. The labeled cells we.-e harvested. washed once with 
fresh SD medium. and suspended in 300 ..... of TE (10 mM 
Tris. pH 8. 1 mM EDT A). Cells were broken with glass 
beads and centrifuged to recover a clear supernatant. This 
extract was then immunoprccipitated by RNase III antisc~ 
rum and analyzed by sodium dodecyl sulfate (SDS)-poly· 
acrylamide gel electrophoresis as previously described (12). 
29H9 
Southern blot analysis. Yeast DNA was prepared as de-
scribed by Sherman et al. (22). DNA was transferred to 
nitrocellulose essentially as described by Southern (23). An 
850-basc-pair fr.tgment containing the RNa~ HI gene was 
nick translated and used as the probe. Hybridization was 
performed in 3 x SSC (l x SSC is 0.15 M NaCl plus 0.015 M 
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sodium citratc)-3 x Dcnhardt solution (4)-0.5% 50S at 65°C 
for 12 (0 16 h. The filters were washed in 3x SSC-O.5% SDS 
at 65"C for 2 h, dried, and analyzed by autoradiogmphy. 
Total yeast RNA isolation and RNA blot analysis. For 
preparation of total RNA from S. ccrevisiae, 200-ml log-
phase cultures (2 x 107 cells per ml) were harvested and 
suspended in 2.5 ml of LETS buffer (0.1 M Liel. 0.01 M 
EDTA, 0.01 M Tris hydrochloride [pH 7.4], 0.2% 50S). 
Cells were then broken with glass beads in 3 ml of phenol 
equilibrated with LETS buffer. LETS buffer (5 mt) was 
added. and the aqueous phase was extracted twice with 5 m! 
of phenol-chloroform-isoamyl alcohol (25:25:1) and once 
with chloroform. Finally. total yeast RNA was precipitated 
with 0.1 volume of 5 M Lie) and 2 volumes of ethanol. 
Nick translation or DNA probes and transfer of total RNA 
were performed essentially as described by Maniatis et al. 
(15). Filters were prehybridized at 42°C for 2 to 4 h in 5x 
SSC- 50% formamide- 5 X Denhardt solution-O.5 mg of calf 
thymus DNA per ml-O.l% SDS. Hybridization was per-
formed undcr thc same conditions, except that the concen-
tration of calf thymus DNA was 0.1 mg/ml and a denatured 
probe (2 x 107 to 3 X 107 cpm) was included. After 
hybridization for 16 to 20 h. filters were washed with a 
solution containing 50% formamide and 5x SSC at 42°C and 
then washed four times at 41"<: with a solution containing S 
mM Tris hydrochloride (pH 7.0), 15 mM NaC!, 1 mM 
EDTA, and 0.1% SOS. The dried filters were then autora-
diographed. 
Radioactively labeled RNA was prepared by adding 1 mCi 
of J2P04 to cultures at 8 h after induction. The cells were 
labeled for Shand then extracted as described above. The 
amount of label in L dsRNA, 15S rRNA, and 18S RNA was 
determined in appropriate gel slices from a 0.5% agarose gel. 
Assays for RNase 1[[ activity. The standard mixture (SO I-ll) 
for assaying RNase III contained 0.13 M NH-4C1, 0.01 M 
magnesium acetate, 5% sucrose, and 0.01 M Tris hydrochlo-
ride (pH 7.9) as described by Robertson et al. (21). The [3Hj 
poly(A . U) copolymer substrate (21) was kindly provided 
by H. Robertson of Rockefeller University, and the reaction 
was performed at 3rc for 30 min and terminated by addition 
of 5% trichloroacetic acid, Bovine serum albumin carrier 
(0.2 mg) was added, and the precipitate was collected on 
Whatman GF/A glass fiber filter pads. The pads were dried 
and counted. An alternative substrate used a total yeast 
RNA p.eparation, described above, which was subjected to 
electropho.esis on a 0.5% agarose gel buffered with 40 mM 
Tris (pH 7.8)-20 mM sodium acetate-2 mM EDTA. RNase 
III activity was detected by specific degradation ofL dsRNA 
at various RNase III concentrations (see Fig. 4). Purified 
RNase III was provided by J. Ahnn (unpublished data). 
DNase I and RNase A hydrolysis. Total RNA preparations 
were incubated at 3rC for 30 min with DNase I (40 fL&Iml) 
and RNase A (4 I-lg/ml) in a buffer containing :20 mM 
K 2 HP0-4 (pH 7.6), 4 mM MgClz• and 0.6 M NaCI. To detect 
both Land M dsRNA species. total RNA samples were 
applied to a 3.S% polyacrylamide gel after DNase I and 
RNase A digestion. Electrophoresis was performed with 40 
mM Tris hydrochloride (pH 7.8}-20 mM sodium acetate-2 
roM EOTA. 
RE.sUL TS ANI) DISCUSSION 
Exprcssion of RNase III. To express RNase III in S. 
(·uC'\ 'isiw'. a GALlO expression system (2) was used which 
allows strong and rapid induction or transcription or the 
cloned gene when galactose is provided as a carbon source. 
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FIG. 1. Production of RNase HI in S. cerc,·isiae. S. cerevisiae 
DMMl-15A cells harboring plasmid pPY2 or YEp51-Sl were grown 
to 107 cells per ml with raffinose (ullinduced cultures) or galactose 
(induced cultures) as the carbon source and labeled for 1 h with 
[35S1methionine. Samples of extracts prepared from the labeled cells 
were immunoprecipitated with antiserum to RNase III and then 
analyzed by SDS·polyacrylamide (17.5%) gel eicctrophoresis. [m-
munoprecipitated (lanes 1 to 4) and total (lanes 6 to 9) extracts of 
induced (+) and uninduced (-) cultures harboring either pPY2 
([anes 3, 4. 6. and 7) or YEp.5I-Sl (lanes I, 2, 8, and 9) ace presented. 
Lane .5 contained an immunoprecipitated extract of E. coli wntain-
ing ))S-Iabeled RNase ilL The arrow shows the position of RNase 
III. 
The shuttle vector YEpSl contains. in addition to the 
GALlO promoter. the 2fl-m high-copy-number origin of rep-
lication and the yeast LEU2 gene. An 8SO-base-pair HincIl-
BamHI fragment from pTDIOl (3) containing the RNase 111 
gene was inserted into the Sail and BamHI sites of YEpSI. 
thus placing the protein-coding sequence between the appro-
priate promoter and termination sites. The cloned fragment 
contains 24 base pairs upstream of the initiating ATG from 
the E. coli gene, in which there are no other initiation or 
termination codons. 
To examine the expression of E. coli RNase III in S. 
auvisiae, cells carrying YEpSI-RNase III (designated 
pPY2) were labeled with {lSSjmethionine and the total cell 
protein was analyzed by SOS-polyacrylamide gel electro-
phoresis. As a conlcol throughout this study_ the same strain 
(DMMl-lSA) carrying a YEpS1 d erivative carrying the gene 
for protein S of Myxococcus xanthus (10) "''as used. A band 
with a mobility identical to that of E. coli RNase III was 
found in the extract from induced cultures harboring pPY2 
(Fig. 1, lanes 6 and 7) . A corresponding Nod was absent 
from extracts of cultures harboring YEp51 -Sl which wc.e 
induced under similar conditions (Fig. 1. lane 8). Immuno-
precipitation of the above-described extracts with RNase III 
antiserum demonstrated that the suspect~ band was .c-
(ained and thus contained material that cro·ss-reac(s with 
RNase III (compare lanes 3 and 4 in Fig. 11-
Strains containing eithcr pPY2 or YEpSI-SI exhibited the 
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FI G. 2. Growth of $ . cerevisiae DMMI·15A after induction of 
RNase Ill. DMMl-15A harboring pPY2 or YEp'sl-Sl was first 
grown 10 stationary phase in glucose.containing medium and then 
inocula ted into either galactose- or glucose-containing medium. (A) 
Culture turbidity was monitored by optical density a t 660 11m. (8) 
Cell growth was monitored by a viable count on glueose-containing 
plates . Symbols of respective plasmid and growth medium: e , 
pPY2-galactose; D. pPY2-glucose : O. VEp51-S1- galactose; _, 
VEp5l-S1- glucose. 
sa me growth kine tics as monitored by culture turbidity when 
glucose was used as the carbon source (Fig. 2A). In contras t. 
whe n galactose was used as the carbon source. the strain 
harboring pPY2 grew more slowly than the strain harboring 
YEp51-SI (Fig. 2A) . The RNase III-induced culture stopped 
growing after 16 to 18 h at only about 20% of the turbidity of 
the control culture . The turbidity of the RNase llI-induced 
culture eventually started to increase again because of the 
growth of a fraction of the culture which survived the lethal 
effect of RNase III induction. A striking effect on cell 
viability was observed after induction of RNase III (Fig. 28). 
Within 3 h, the viability of induced cultures harboring pPY2 
dropped lO-fold. and after 12 to 15 h the frequency of 
surviving cells was 4 x 10-.5 to 5 X 10- .5. It was of interes t 
that in the initial period after RNase III induction there was 
no change in cell morphology and the cells appeared to bud 
normally, as observed by phase-contrast light microscopy. 
However. after 10 to 12 h, the RNase' III-induced cell s 
appeared slightly larger than the control, and at 18 to 20 h. 
extremely large cells were observed (Fig. 38). in contrast to 
control cells harboring YEp51-Sl (Fig. 3A). A yeast strain 
harboring one copy of the RNase III gene integrated into the 
chromosome displayed the same lethal effect and cell mo r-
pho logy in response to induction as the 2J.l.m-derived pPY2 
plasmid described (data not shown). 
Activity of RNase III. Two a ssays were used to determine 
RNase III activity in yeast Iysates. Initially we used the 
method of Robertson et al. (21). in whic h a JH-Iabeled 
double~stranded poly(A. U) copolymer is (he RNase III 
substrate . Significant reduction in JH~labclcd tr ichloroacetic 
acid-precipitable counts was found only in the lysate of the 
galactose-induced s train harboring pPY2 (data not shown) . 
A seco nd activity assay used ",durally existing ds RNA froUl 
S . (·('r(" I·; ... ilH.'. Many S. (.·u i' l'i ... it.t' slrdins contain dsHNA 
whic h is e ncapsidated in viruslike particle s (27). Twu types 
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FIG. 3. Cell morphology aFter induction of RNasc lit. Cultures 
induced for 18 h (described in the legend to Fig. 2) harboring 
YEpSI ·Sl (A) or pPY2 (8) were subjected 10 phase-contrast light 
microscopy (magnification, x640). 
of d sRNA molecule are usually found in virus like panicles of 
S. cere l';siae. The larger. designated L. e ncodes the capsid 
protein (9). whereas the smaller dsRNA. designated M . 
encodes a toxin (1) which is secreted and can kill other S. 
cerel'isiae strains. L dsRNA from a preparatio n of total 
RNA of S. cu el';siae was degraded by purified RNase HI 
(Fig. 4). The dose-de pendent degradation o f L d sRNA 
appears to be specific . s ince rRNA (25S and 18S) was 
unaffected. Figure 48 presents the effects of c rude yeast 
Iysates o n L dsRNA. Only [ysates from cultures harboring 
pPY2 which were induced by galactose caused specific, 
dose-de pende nt digestio n of L d sRNA (lanes 5 and 6). 
Lysatcs from uninduced c ultures harboring pPY2 (lane 4) or 
Iysates from strains harboring the COQlrol plasmid YEp51-S1 
(lanes 2 and 3) exhibited no RNase III activity by this assay. 
The lethality of RNase III induction in S. art!vis iae raises 
the question of the target of this enzyme in vivo. One 
possibility is that RNase III causes a general disruption of 
FIG . ... Auay of RNase III activit y in yeast (yules. (A) Total 
yeast RNA (20.,.g) was treated with 0 , 0 .... Of' 10 .,..g(lanes I, 2. and 
3. respectively) of purified RNase III at 37"C for 30 min. subjected 
to 0.:;% agarosc gd eleclrophoresis. and staioed with ethidium 
bromide. (8) Strain DMMl-15A harboring pl'Y~ or VEp'sI-SI was 
grown in either galactose- or gluCQse-containing medium as de-
scribed in the legend to Fig. 2. Cultures (5 ml) were harvested al an 
optic:.1 dens.ity of 1 at 660 nm, and cell cltr.lClS were: prepared . 
Samples oflhese edracu were incubated .. ·ilh INal yeal't RNA and 
suhjected to gel electrophoresis as described ab<.wc. The gel order in 
panel U with respect to Ihc culture cxtroict u~cd Criasmid harbored· 
growth medium I was : IS follows: I. no C\lracl ....w.:d ; ~. 5 .,,1 of 
YEp5 1 ·S I-&luc~; 3. 5 ."g of YEp51-SI -g.al;ocIOSC ; " . 5 .... 1 uf 
pl'Y2-~lucosc ; S. :; .,,1 of pl'Y2.galactose : t. . 1 ,..1 N rl'Y!-plaetose. 
Symhols: L . L dsRN" : e. 2.'iS rRN" : C . HtS rR:-':A . 
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FIG. 5. (A) Stability of Land M dsRNAs in S. cerevi,\'iae after 
induction, Total cell RNAs from cultures harboring pPY2 or YEp51-
Sl grown for 6 h in either galactose (+)- or glucose (-)-containing 
medium were treated with RNase A and DNase I (as described in 
Materi;ll s and Methods), subjected to 3.5% polyacrylamide gel 
electrophoresis, and stained with ethidium bromide. Lanes: 1 and 2, 
RNA from DMMl-15A::pPY2; 3 and 4, RNA from DMMl-
15A::YEp51-SL (13) Land M dsRNAs in variants resistant to RNase 
III induction. Total cell RNAs from variants resistant to RNase III 
induction we re analyzed as described for pand A, RNA was 
preparo!d from induced cultures of toxin-negative variants (K - ; 
lanes 1 to 3), toxin-positive variants (K+; lanes 4 to 6), DMMl-
15A::pPY2 (R3 ; lane 7), and DMMl-15A::YEp51-Sl (SI; lane 8). 
RNA stability or synthesis or both. The double-stranded 
killer RNA was considered to be useful for probing RNase 
III in vivo since it is an RNase III substrate in vitro (Fig. 4). 
[n contrast to the in vitro result , · however. killer dsRNA 
appears to be stable after induction of RNase HI in vivo. The 
polyacrylamide gel pattern for both Land M dsRNAs was 
the same with all four culture extracts examined (Fig. SA). 
Furthermore, RNA preparations from cells that were labeled 
8 h after induction incorporated the same proportion of 
32P04 into L killer RNA relative to its incorporation ioto 
rRNA (data not shown). According to these results. RNase 
III does not cause specific degradation of L RNA in vivo. 
and we could not detect any effect on newly synthesized 
double-stranded L RNA. 
A reasonable explanation for the stability of killer RNA in 
vivo may be the protection of dsRNA by proteins associated 
with the viruslike particle (27). [n this regard. eucaryotic 
RNAs exist in vivo in the form of ribonucleoproteins which 
may render these RNAs unavailable for digestion by non-
specific RNases. RNAs involved in protein synthesis. such 
as rRNA, mRNA, and tRNA, do not seem to be the primary 
target of RNase III, since protein synthesis was not shut off 
after induction. Furthermore, at 12 h after induction, incor-
poration of (lsS]methionine into a culture harboring pPY2 
was still 3S% of the incorporation into a culture harboring 
YEp51-Sl. The total RNA extracted from RNase ill-in-
duced cells exhibited an unchanged pattern of rRNA on 
ethidium bromide-stained gels. RNA blot analysis of actin. 
LEUl. and RNase III mRNA from S, cerevisiae exhibited no 
significant differences in the amounts of these mRNAs 
because of RNase HI induction . [n addition. at 12 h after 
induction of RNase III, incorporation of [l2p)phosphate and 
[3!'S)methionine appeared to be affected to the same degree 
(total incorporation was about 3S% when compared with that 
of a control culture). These results do not support the 
hypothesis that RNA. in geneml, is destabilized by expres-
sion of RNase III in S. arevisiae. Instead. the effect seems 
to be on a specific target. presumably a cytoplasmic dsRNA 
moiety. 
Resistance to RNase III induction. As described earlie r. 12 
to 15 h after induction of culturcs harboring pPY2. variants 
resistant to RNase III induction we re isolated at a frequency 
138 
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of 4 x 1O- ~ to 5 x 1O- ·~ . We cxamined the ability of RNase 
Ill-resistant variants to produce toxin cncoded by the M 
dsRNA. Two ·hundred independently isolated variant colo-
nies were spotted onto a lawn ofa toxin -sensitive strain. We 
found that 10% of these RNase III -resistant variants did not 
produce detectable amounts of toxin by this assay. All these 
killer-negative RNase HI-resistant strains we re found to lose 
M dsRNA concomitantly (Fig. 58. lanes I to 3). In both 
killer-positive and killer-negative strains . (he L dsRNA 
appeared to be intact (Fig. SB. lanes 1 to 6). [n a similar 
sample of induced cultures harboring YEpSI-Sl, no toxin-
negative strains were isolated. As mentioned earlier. neither 
the stability nor the synthesis of dsRNA appeared to be 
affected by RNase III induction; thus. it is not clear how M 
dsRNA was cured in some RNase HI-resistant variants. It is 
possible that RNase m has a subtle effect on stability or 
segregation of this dsRNA. Since it is known that cyclohex-
imide (7). 5~fluorouracil (17), and yeast growth at high 
temperatures (26) can cure the cell of M dsRNA. it is also 
possible that M dsRNA was cured as a result of some 
metabolic changes caused by RNase III induction. 
It was of interest to examine these RNase III-resistant 
variants further to determine whether the mutation occurred 
on the chromosome or on the plasmid. Southern blot analy-
sis of K+ and K- strains (data not shown) revealed that both 
the plasmid and its 8S0-base-pair RNase III gene insertion 
appeared to be unaltered. Surprisingly, it was found that, by 
densitometric scanning of SDS-polyacrylamide-protein gels , 
similar amounts of RNase III protein were produced after 
induction of pPY2 in both the wild-type and variant strains 
(data not shown). The variants tested at different times after 
induction also exhibited the same level of RNase III activity 
as the wild type. as shown by two different assay systems 
described earlier (data not shown). 
RNase III resistance due to a mutation in the RNase III 
gene. To determine whether the genetic change accompany-
ing RNase HI resistance was chromosomal or occurred 
within the plasmid pPY2. one of the K+ RNase III-resistant 
variants was analyzed further. This variant was cured of its 
plasmid. and conversely the plasmid itself was isolated from 
the variant cells. When wild-type cells transfonned with 
either pPY2 or the variant plasmid (designated SPI) were 
compared. only cells containing the original plasmid, pPY2, 
displayed the lethal phenotype. When the variant strain 
(designated BlO) harboring these same plasmids was 
checked, cells harboring pPY2 displayed the lethal pheno-
type, whereas cells harboring the varianl plasmid were 
resistant to induction. These results indicate that RNase [II 
resistance was due to the variant plasmid. Finally. the 
8SO-base-pair RNase III-containing fragm~nt from the vari-
ant plasmid was cloned into the original YEp5I vector. Cells 
harboring this plasmid did not exhibit the lethal phenotype, 
confirming that the genetic alteration leading to RNase III 
resistance had occurred within the 85O-base-pair RNase III 
gene-containing insert. 
The results described above indicat~ that the RNase III 
reSistance mutation occurred in the structural gen~ of RNase 
Ill. The production of the altered RNase III appeared to be 
at the same level as that of the wild-type RNase III (Fig. 6) . 
Furthermore , the mutated RNase was fully active whe n 
tested with dsRNA as a substrate. Ther~fore. the mutation in 
RNase III possibly changes the specificity of the en:tyme in 
vivo in such a way that it does not recO!!nizc its le thal targe t 
anymore. In this regard it should be nOled that RNase HI 
specifically cleaves only certain singlc-strdnd<:d RNAs of E. 
coli in vivo (6) . Alternatively. RNase III may require a yeast 
V(H . . !70. 19H8 
FIG. 6. Production of RNase III in yeast strains transformed 
with original and variant plasmids. Cell labeling. immunoprecipita-
lion . and electrophoresis we re as described in the legend to Fig. 1. 
Ex tracts of induced culcures of DMMI-1SA::YEp51-SI (lane I). 
BK3::pPY2 (lane 2). BK3::SPI (lane 3). DMM1-1SA::pPY2 (Iartc: 4), 
DMMI · 15A::SPI (lane 5). and an original RNase III-resistant vari-
anI. K"'2 (lane 6). were used. Lanes 7 to 12 contained immunopre-
cipilated samples of extracts shown in lanes 1 to 6. respectively. 
pPY2. original RNase lII-containing plasmid; SPI. variant plasmid; 
OMMl-15A. wild-type strain; BK3, a resistant strain cured of its 
plasmid. 
component for its activity in vivo. A mutation in RNase HI 
blocking the interac tion between these two components 
would res ult in loss of the lelhal activity in vivo. Since the 
na tive RNase III enzyme has been shown to be a dimer of 
two homologous polypeptides (5), it is also possible that a 
mutation rendering the protein unable to form dimers would 
affect its activity in vivo. In this respect, i.t is interesting to 
examine whether the mutated RNase III gene from S. 
cerf!v;siae can complement a chromosomal RNase 111 muta-
tion in £. coli (13). 
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